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Colonization of the gastrointestinal tract by Escherichia coli is dependent upon its 
ability to compete with the commensal microflora. We have established that nutrient 
acquisition is important for competition and fitness of E. coli strains in the 
mammalian intestine. However, the importance of respiration and the respiratory 
pathways used by E. coli for colonization was unknown prior to this study. We used a 
systematic mutational approach to test the hypothesis that respiratory metabolism is 
important for E. coli to colonize the mouse intestine.  We found that a strain lacking 
cytochrome bo3 oxidase (cyoAB) co-colonized with the wild-type.  A mutant lacking 
the high oxygen affinity terminal cytochrome bd oxidase (cydAB and cydDC) failed 
to initiate and could not colonize. Of the four anaerobic respiratory pathways, 
dimethylsulfoxide (DMSO) reductase (dmsAB), trimethylamine-N-oxide (TMAO) 
reductase (torCA), and nitrite reductase (nirBD) were found to be unimportant, while 
nitrate reductase (narG, narZ, and napDA) and fumarate reductase (frdA) mutants 
were able to initiate colonization but showed major defects in maintenance.  Our 
findings lead us to conclude that respiration of oxygen provides a competitive 
advantage to E. coli in vivo despite the low availability of its preferred carbon 
sources.  E. coli also requires use of alternative anaerobic electron acceptors, such as 
nitrate and fumarate, to be competitive in the intestine.  Furthermore, respiratory 
flexibility allows E. coli to maximize its colonization efficiency to ensure its success 
in the mammalian gastrointestinal tract.  The experiments described in this study 
suggest that facultative anaerobes may make the intestinal environment more 
anaerobic, thereby promoting the stability of the predominantly anaerobic microflora.  
Indeed, the intestinal environment is likely microaerobic, oxygen tension almost 
certainly fluctuates in the intestine.  These experiments provide the first evidence for 
an aerobic microhabitat in the intestine and suggest a hierarchy of alternative electron 
acceptors support colonization.  Additionally, the results show that energy storage in 
the form of glycogen may also be important during times of nutrient limitation to 












Humans live in close association with a large number of microorganisms that are 
found on the skin, in the mouth, and in the intestinal tract.  Many different bacterial 
species can colonize the large intestines of humans and animals.  The human 
gastrointestinal (GI) tract is host to a complex and dense microbial ecosystem.  There 
are approximately 10
12
 microorganisms per milliliter of luminal contents consisting of 
an estimated 800 different bacterial species: the intestinal microbial population 
outnumbers human cells by approximately 10:1 (30, 36, 78, 117, 234).  Escherichia 
coli is the predominant facultative anaerobe found in the mammalian GI tract (85).    
However, despite being one of the best understood microorganisms, precisely how E. 
coli colonizes the mammalian large intestine still remains unknown (218).   
 
The gut microflora is dependent on the availability of both nutrients and electron 
acceptors to establish colonization.  The intestinal microbiota is important for many 
metabolic functions that support the digestive system and also provides resistance to 
bacterial infection.  Control and manipulation of the intestinal microflora may prove 




1.2 Gastrointestinal tract 
 
The human gastrointestinal tract includes the small and large intestine.  The small 
intestine is responsible for chemical digestion and nutrient absorption and is divided 
into three sections: the duodenum, the jejunum, and the ileum.  Unlike the small 




 microorganisms per milliliter 
of intestinal contents), the large intestine contains the majority of intestinal 
microorganisms (approximately 10
12
 microorganisms per milliliter of intestinal 
contents) (157).  The large intestine is the terminal part of the digestive tract and 
consists of three parts: the cecum, the colon, and the rectum.  The primary function of 
the large intestine is to reabsorb water and inorganic salts where the intestinal 
contents are compacted and eliminated as feces.  Unlike the small intestine, the 
mucosal surface of the large intestine is smooth and contains no intestinal villi.  The 
colonic epithelial lining is estimated to shed 2 x 10
6 
to 5 x 10
6
 cells per minute (61).  
A thick layer of mucus overlies the epithelium and is largely made up of mucin, 
glycoproteins, proteins, glycolipids, lipids, and sugars (49, 157).  The mucus layer is 
in a constant state of synthesis and secretion, the contents of which are degraded by 
the intestinal microflora.  The mucus layer of a conventional mouse turns over 
approximately every two hours (157, 193).  E. coli commensal strains have been 
shown to colonize the cecum and colon of the mammalian intestine, specifically in 
the mucus layer (231). 
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To colonize the intestine, bacteria ingested in relatively low numbers must acquire 
nutrients to grow and persist in high numbers.  In general, the nutrients that support 
persistence of the intestinal microflora are thought to be fermentable carbohydrates 
(203).  Little attention has been given to the possible role of bacterial respiration for 
coupling ATP generation to carbohydrate oxidation.  If it is found that respiratory 
metabolism is important for bacteria in vivo, then electron acceptors need to be added 
to the list of nutrients that support colonization.  The nutrient-niche hypothesis states: 
to coexist, each species in the intestine must grow better on one or a few limiting 
nutrients than all other species. Thus, ecological niches within the intestine are 
defined by nutrient availability (88).  Our recently completed systematic analysis of 
bacterial carbon nutrition in the intestine calls into question the number of carbon 
sources that might support growth of a single species because we showed that at least 
seven monosaccharides contribute to a larger or lesser extent to colonization of E. coli 
(39).  This finding suggests the nutritional diversity of E. coli in the intestine is a 
reflection of both its biochemical flexibility and the availability of carbon sources.  E. 
coli is nearly equally flexible in its energy yielding metabolism.  This dissertation 
addresses whether bioenergetic flexibility and the availability of electron acceptors in 
the intestine is important for colonization of a facultative anaerobe. 
 
1.3 Intestinal microflora 
 
The intestinal microbiota has been the subject of many studies since it was first 
discovered to be important to maintain gut stability, and therefore, a healthy condition 
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for human hosts.  In 1965, Dubos et al. described the basic principles of the microbial 
ecology of the gastrointestinal tract (73).  They hypothesized that the gastrointestinal 
microflora, which they termed the “indigenous flora” of any animal species is made 
up of the microbes present during the evolution of the animal (nonindigenous 
microbes), the ubiquitous microbes found in the animal’s community established in 
all its members (normal microbiota), and the pathogenic microorganisms that have 
been accidentally acquired and are capable of persisting in the system (73).  A 
microbial ecosystem is defined as a complex community of microorganisms in a 
particular environment and the surroundings with which the organisms are associated.  
An ecosystem contains habitats and niches for the residing microorganisms.  Habitats 
are the physical spaces in the system, and the way an organism makes its living in its 
habitat defines its niche in the ecosystem (234).   
 
The human colon is a dynamic habitat where individual bacteria exist in different 
microhabitats and metabolic niches.  Information regarding the composition of the gut 
microbiota has largely arisen from fecal studies.  The composition of the microbiota 
of human feces has been used to determine the composition of the microbial 
communities in the colonic lumen (234).  A diverse bacterial population has been 
demonstrated to colonize the GI tracts of healthy individuals.  The intestine is a 
challenging area to study due to immense species diversity, the vast range in 
abundance of the resident flora, and the inability to culture many of these species.  Of 
the cultivable microorganisms, the dominant species found in the GI tract are limited 
to obligate anaerobes.  In humans, the obligate anaerobes comprise more than 99.9 % 
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of the cultivable microorganisms (234).  The colonic bacteria include Bacteroides, 
Bifidobacterium, Clostridium, Eubacterium, Fusobacterium, Lactobacillus, 
Peptococcus, Peptostreptococcus, Streptococcus, Enterococcus, Ruminococcus, and 
Veillonella (35, 64, 74, 233, 235, 237).  These bacteria, and many others, form the 
complex and stable community of the GI tract.  The presence of these 
microorganisms in the murine gastrointestinal tract will be considered in the next 
section. 
 
1.4 Streptomycin-treated mouse model 
 
 
There are both advantages and disadvantages in using in vivo models for intestinal 
colonization.  There are three colonization models used to study colonization of the 
intestinal tract.  The first of these models is the conventional mouse model.  This 
mouse contains a complete microflora that allows for the examination of the 
interactions between the already established microbial populations and invading 
microbes.  However, this model is not always practical because colonization is 
difficult or impossible for many invading microorganisms, due to colonization 
resistance.  Colonization resistance refers to the ability of the indigenous intestinal 
microbiota to prevent colonization of or provide a barrier to newly introduced 
pathogenic bacteria (157).  The second model for intestinal colonization studies is the 
gnotobiotic animal, or germfree animal.  This model is advantageous in that there is 
an absence of the indigenous microflora and colonization is readily achieved, even for 
organisms with limited fitness for colonization, because there is no competing 
microflora in gnotobiotic animals.  A major drawback to this model is that handling 
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gnotobiotic animals is more complicated and rather expensive.  Furthermore, the 
intestinal physiology of the gnotobiotic mouse varies from that of conventional 
animals in that there is a higher oxygen tension found in the intestine as well as a thin 
and villous mucosa in the cecum (231, 234).  The third in vivo model for colonization 
is the streptomycin-treated mouse model.  This model was first developed in 1954 
when mice were given an oral administration of streptomycin and infected with 
streptomycin resistant strains of Salmonella enteritidis (23).  Subsequently, the 
microecology of the cecal contents was determined to be altered following 
streptomycin treatment (92, 116, 236).  A decrease in the facultative anaerobic 
enterococci, streptococci, and lactobacilli was observed (236).  Nonetheless, the 
Bacteroides and Eubacterium populations were unaltered in the cecal contents of 
streptomycin-treated mice (116).  In addition, the anaerobic population was found to 
be equivalent in numbers in both streptomycin-treated and conventional mice, 
approximately 1 x 10
9
 to 2 x 10
9
 CFU/g of contents (116).  Thus, the streptomycin-
treated mouse model allows for the establishment and examination of invading 
microbes in the presence of high numbers of strict anaerobes in the mammalian GI 
tract (212).  Also, the streptomycin-treated mouse model is inexpensive and has been 
widely used to study E. coli and Salmonella Typhimurium colonization of the mouse 
intestine (309).  The use of this model is simple, demanding only that streptomycin 
sulfate be administered in the drinking water (5g/liter), and that the strains of bacteria 
fed to the animals be resistant to streptomycin (295). 
 
1.5 E. coli colonization of the mouse intestine 
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Colonization of the gastrointestinal tract by commensal and pathogenic organisms 
is dependent on the ability of these organisms to compete with the existing 
microflora.  Colonization is the first step in gastrointestinal infections and is defined 
as the stable persistence of a microbial population without the reintroduction of the 
bacterium to the animal (232, 294).  E. coli O157:H7 and K-12 colonize the 
mammalian intestinal tract in the presence of the existing indigenous intestinal 
microbes.  Strains of E. coli fed to streptomycin-treated mice grow from low numbers 
(10
5
 CFU/g of feces) at 5 hours postfeeding to high numbers (10
8
 CFU/ g of feces) by 
24 hours postfeeding (39, 157).  There are two defined stages of intestinal 
colonization: initiation and maintenance (157).  The first stage of colonization, 
initiation, continues after the introduction of a bacterial strain up until day 3 
postfeeding (157).  Following initiation, wild-type E. coli strains normally reach a 
stable population of about 10
8
 CFU/g of feces.  This phase of colonization is known 
as maintenance and occurs after day 7, presumably when nutrients become limiting 
(157).  
 
Using the streptomycin-treated mouse model, mice are simultaneously fed two 
competing strains of E. coli. The relative ability of each strain to colonize the 
intestine is then monitored over a period of 15 days by conducting fecal plate counts.  
Genetic manipulation of E. coli strains allows for the role of particular genes of 
interest in their colonization ability to be examined during competition with wild-type 
parent strains.  Therefore, the relative fitness of the mutant strains can be measured 
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during colonization (160).  The degree to which mutant strains are defective in 
colonization during competition with their wild-type parent is categorized as: major, 
significant, minor, or none.  Mutant strains that do not compete effectively with wild-
type strains during initiation or maintenance are classified as having a colonization 
defect based on the degree to which the mutant strain is able or unable to colonize.  
The level of colonization is described by the log difference in CFU/g of feces.  A 
major colonization defect is marked by a 3 log difference or greater between that of 
the mutant and wild-type strain.  A significant colonization defect is a 1.5 to 3 log 
difference, whereas a minor defect is characterized by a 1 to 1.5 log difference.  
Mutant strains that are able to co-colonize with their wild-type parent strains are 
recognized as having no colonization defect.  The physiological factors involved in E. 
coli colonization of the murine gastrointestinal tract, with respect to respiratory 
metabolism, will be the focus of this dissertation.  The remainder of this chapter is a 
discussion of metabolic capabilities of the E. coli cell. 
 
1.6 Respiratory oxidoreductases 
 
The respiratory metabolism of E. coli in its natural habitat, the GI tract, has been 
completely ignored.  However, recently more interest has developed regarding the 
metabolic pathways used by E. coli and other microorganisms to produce energy for 
growth and survival during colonization of mucosal surfaces (39, 248).  These topics 
are addressed in Chapter 2 of this dissertation.  In order to survive changing 
environmental conditions and the challenges faced in the flourishing 
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microenvironment of the GI tract, E. coli must be able to adapt to a variety of growth 
conditions including electron acceptor availability.  E. coli is able to grow aerobically 
by respiration, and in the absence of oxygen by anaerobic respiration using alternative 
electron acceptors (93).  If oxygen, nitrate, nitrite, dimethylsulfoxide (DMSO), 
trimethylamine N-oxide (TMAO), and fumarate are unavailable, then E. coli can also 
produce energy by fermentation (93).  The ability of facultatively anaerobic bacteria, 
such as E. coli, to alter their respiratory metabolism suggests a type of respiratory 
flexibility that the organism displays according to its environment.  However, the 
terminal oxidoreductases used by the organism to colonize the intestine in vivo have 
remained unknown, warranting further investigation.  The respiratory metabolism of 
E. coli in vivo is the main focus of this dissertation and is further addressed in 
Chapters 2 and 3.  A model of E. coli’s respiratory pathways examined in this 
dissertation is shown in figure 1.1. 
 
The electron transport system is the major source for ATP production for many 
microorganisms.  The electron transport chain functions to regenerate NAD
+
, 
nicotinamide adenine dinucleotide, and provide ATP to support cellular processes.  
The process by which ATP is formed is a result of the transfer of electrons from 
reduced nicotinamide adenine dinucleotide (NADH) to an electron acceptor, such as 
oxygen, through a series of electron carriers located in the cell membrane.  An 
important function of respiration is the generation of an electrochemical gradient, or 
proton motive force, across the cytoplasmic membrane.  Proton motive force is 
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the respiratory chain, which pumps protons to the outside of the cell.  Furthermore, 
the respiratory chain maintains redox balance by regenerating NAD
+
 from NADH.  
Aerobic and anaerobic respiratory pathways allow E. coli to oxidize a wide array of 
substrates, while passing the electrons on to a number of different oxidants.  There are 
three types of respiratory components: substrate-specific dehydrogenases, responsible 
for the oxidation of organic substrates and feeding electrons to the electron transport 
chain; quinones, small membrane soluble molecules which serve as electron carriers; 
and the terminal oxidoreductases, responsible for the reduction of the terminal 
electron acceptors being used. The amount of each of these respiratory components is 
carefully regulated in order to ensure the optimal use of the electron transport chain 
according to the substrates and electron acceptors available and the physiological 
needs of the cell.   
 
E. coli has the ability to combine its various respiratory components to alter its 




 ratio) over a 
considerable range.  This suggests that the optimized electron transport chain does not 




.  Instead, one principal function of the electron 
transport chain, independent of its bioenergetic efficiency, is to maintain redox 
balance and regenerate NAD
+ 
from NADH.  The cells have to simultaneously balance 
the challenging needs for bioenergetic efficiency, NAD
+
 regeneration and net electron 
flux, as well as oxygen scavenging.  This balance is accommodated by E. coli’s rapid 
adjustment of the electron transport chain components in response to availability of 
substrates and electron acceptors in its microenvironments.   
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Some indigenous microbes of the GI tract, such as E. coli, have the capability to 
generate energy by aerobic oxidative phosphorylation.  Therefore, these 
microorganisms may occupy habitats in vivo where oxygen is available.  These 
aerobic habitats could be in close proximity to epithelial cells where O2 molecules 
might pass from the blood through the epithelium to the adjacent bacteria (164).  E. 
coli may be responsible for creating and maintaining an anaerobic, or oxygen free, 
environment and conditions of a low oxidation-reduction potential that favor the strict 
anaerobes present in the large bowel (234).  The existence of such niches has not been 
established and is considered in Chapter 2 of this dissertation. 
 
Since E. coli has both a diverse and flexible respiratory metabolism capable of 
respiring favorable electron acceptors, such as oxygen, this organism is, therefore, 
able to maintain a stable population in changing microhabitats (123).  E. coli has two 
respiratory oxidases, cytochrome bd and cytochrome bo3.  The cytochrome bd 
ubiquinol oxidase (encoded by cydAB and cydDC), which is synthesized under low 
oxygen or microaerophilic conditions, has an extremely high affinity for oxygen and 
is used when oxygen concentrations are low.  Alternatively, E. coli can use a low 
affinity cytochrome bo3 oxidase (cyoAB) that is expressed under high oxygen tensions 
to respire oxygen.  Both of these enzymes are quinol oxidases.  Cytochrome bo3 is a 
member of a large family of proton pumping heme-copper respiratory oxidases (38, 
92).   Cytochrome bd is not a member of the heme-copper oxidase family and is 
found in only a small number of bacterial species, namely the enterics (100, 148).  
Regulation of aerobic respiration is primarily mediated by a two-component 
 14 
regulator, ArcA and ArcB (51, 126, 128, 131, 133, 134).  ArcA acts to repress cyoA 
operon expression and activates cydAB expression under microaerobic conditions (50, 
53, 91, 126, 129, 130, 285).  Control of respiratory metabolism and its role in 




) respiration is widespread amongst bacterial species, including the 
enterobacteria (290).  Nitrate is the most energetically favorable terminal electron 
acceptor of the anaerobic electron acceptors used by E. coli.  Additionally, nitrate has 
been demonstrated to inhibit the synthesis of other reductases, which eliminates the 
use of many of the other terminal electron acceptors (93).  This particular role sets the 
basis for a hierarchy of electron acceptors that is used by E. coli and is discussed in 
Chapter 3 of this dissertation.  E. coli O157:H7 and K-12 have multiple respiratory 
nitrate reductases (185, 203).  The primary E. coli nitrate reductase (encoded by 
narGHI) is a cytoplasmic membrane-bound enzyme that is synthesized under nitrate 
concentrations greater than 2.5 mM in vitro (263, 300).  Regulation of nitrate 
reductase synthesis, the primary and periplasmic reductase, is provided by the 
regulatory control proteins, Fnr and NarL (26, 27, 41, 105, 300).  Fnr is a global 
regulator that mediates anaerobic respiration for both nitrate and fumarate respiration 
in response to anaerobiosis (168, 259, 260).  However, another level of transcriptional 
control in response to nitrate availability is supplied by the regulatory proteins, NarL 
and NarP (124, 125, 214, 262, 264, 268, 270).  Together, these regulators act to 
control anaerobic respiration in E. coli.  A secondary cytoplasmic reductase (encoded 
by narZYWV) has not been extensively characterized and the physiological role of the 
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enzyme is unclear (22, 25, 93, 124, 125).  However, it is known that the homologous 
enzyme is not regulated by nitrate (40).  Instead, NarZ is RpoS dependent and 
induced during stationary phase (40).  Various bacteria also contain a nitrate 
reductase in their periplasm.  E. coli contains a third nitrate reductase (encoded by 
napFDA) located in its periplasmic space (102, 300). Synthesis of the periplasmic 
nitrate reductase is induced by a low concentration of nitrate during anaerobic 
growth, approximately 1 mM (300).  The expression of the nitrate reductases under 
varying concentrations of oxygen or nitrate has been extensively studied in vitro and 
will be discussed in more detail in Chapter 2 and 3 when nitrate measurements are 
made in vivo. 
E. coli can also use fumarate as an alternative terminal electron acceptor during 
anaerobic respiration (46, 162, 163).  Fumarate reductase (encoded by frdABCD) 
expression requires anaerobic growth conditions; however, its synthesis is repressed 
by the presence of nitrate (118, 127, 155, 258, 265).  Expression of fumarate 
reductase, controlled by anaerobic and nitrate regulation, is mediated by Fnr and 
NarL, respectively (105, 106, 136, 137, 291).  Fumarate is the least favorable of the 
terminal electron acceptors that E. coli can use during anaerobic respiration.  
Alternative electron acceptors that are more energetically favorable than fumarate are 
discussed below.   
E. coli can use multiple alternative electron acceptors for anaerobic respiration, 
the primary reductases for the remaining anaerobic reductase systems including 
nitrite, DMSO, and TMAO.  The most favorable of these electron acceptors is nitrite.  
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Nitrite, (NO2), which is the product of nitrate reduction, can also serve as an 
anaerobic terminal electron acceptor in E. coli (1).  The anaerobic nitrite reductase, 
encoded by nirBD, is the primary reductase that mainly functions to regenerate NAD
+
 
and detoxify nitrite that accumulates from nitrate respiration (93, 199, 226).  
Additionally, enzyme synthesis of the primary nitrite reductase is induced by nitrate 
or nitrite (199).  E. coli has a second nitrite reductase, encoded by nrfAB, located in 
its periplasm (299).  Synthesis of this enzyme is induced only by nitrite and is 
repressed by nitrate (199, 299).  Regulation of both nitrite reductase operons is 
mediated by Fnr and NarL (261).  Alternatively, E. coli can use S- and N- oxides as 
terminal electron acceptors during anaerobic respiration (63).  The primary DMSO 
reductase, encoded by dmsAB, in E. coli requires anaerobic conditions for synthesis 
(21, 228, 229).  However, enzyme synthesis is not induced by DMSO but instead is 
repressed by nitrate, mediated by Fnr and NarL (52, 289, 302).  DMSO reductase has 
a broad specificity that can support anaerobic respiration with either DMSO or 
TMAO (20, 302, 303).  Conversely, the primary TMAO reductase (encoded by 
torCA) in E. coli also requires anaerobic growth conditions for synthesis (10, 254, 
277).  However, synthesis of TMAO reductase is not repressed by nitrate (132, 277).  
Instead, enzyme synthesis is strongly induced by TMAO (253, 254).  Furthermore, 
anaerobic regulation of TMAO reductase is not mediated by Fnr and the mechanism 
of regulation by oxygen is unknown (93, 201).  E. coli has two other alternative 
reductases for DMSO and TMAO.  The ynfEFGHI operon encodes a paralog of 
DmsABC, and the torYZ operon encodes a paralog of TorAC.  The DmsABC, 
YnfEFGH, and TorYZ systems all exhibit broad substrate specificity for S-oxides and 
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N-oxides, and therefore overlap substantially.  The respiratory oxidoreductases used 
by E. coli in vivo and their contribution to colonization are discussed in Chapter 2 of 
this dissertation.      
1.7 Hierarchy of aerobic and anaerobic electron acceptors 
 
The ability to use multiple electron acceptors provides the respiratory flexibility 
and diversity that E. coli is thought to need in order to compete in a densely populated 
habitat such as the mammalian large intestine (44).  In addition, the ability to regulate 
electron transport chain components allows E. coli to preferentially use the terminal 
electron acceptor that yields the maximum amount of energy (105).  This establishes 
a hierarchy of the available electron acceptors that can be used to ensure energy is 
produced efficiently.  The use of these electron acceptors in vitro has been 
extensively studied (132, 269).  However, the hierarchy of these electron acceptors in 
vivo has never been examined and is addressed in Chapter 3 (97), which focuses 
mainly on the terminal electron acceptors oxygen, nitrate, and fumarate since they 
were found to be used by E. coli in the mouse intestine.    
 
The regulation of respiratory gene expression allows E. coli to take advantage of 
the compound that will provide the highest redox potential.  Indeed, the synthesis of 
respiratory enzymes is under hierarchical control to make certain that respiratory 
terminal electron acceptors are consumed preferentially.  Oxygen (E°΄= + 0.82 V) has 
the highest energy yield of all electron acceptors, is preferred over all other terminal 
electron acceptors, and is consumed first (132, 170, 288).  The preferred order of 
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electron acceptors follows the redox potential for the given acceptor where nitrate 
(E°΄= + 0.42 V) produces the maximum amount of energy in the absence of oxygen, 
and fumarate (E°΄= + 0.031 V) produces the least amount of energy among all of the 
alternative terminal electron acceptors (5, 101, 115, 142, 144). 
 
The hierarchical order of preference operates under aerobic and anaerobic 
conditions (283).  The first level of hierarchical control involves the cell’s response to 
oxygen (287, 289).  Aerobically grown cultures only synthesize basal levels of 
anaerobic respiratory enzymes (289).  However, the oxygen sensitive Fnr 
transcription factor activates transcription of anaerobic reductases in anaerobic 
cultures (144, 198, 243).  The second level of hierarchical control involves the cell’s 
response to nitrate that is mediated by paralogous two-component sensor regulatory 
systems, NarX-NarL and NarQ-NarP (45, 86, 167, 293, 310).  The NarX-NarL 
system broadly controls gene expression under nitrate respiration, whereas the NarQ-
NarP system plays a more restricted role in control when electron acceptors, such as 
nitrate, are limiting (97, 140, 141, 298).  Nitrate reductase synthesis is induced and 
simultaneously represses the synthesis of enzymes used for respiring the alternative 
anaerobic electron acceptors, such as fumarate reductase (84, 86, 136, 213, 250, 278, 
279).  In addition, nitrate reduction results in the accumulation of nitrite (227).  This 
then induces the synthesis of nitrite reductase once nitrate is depleted which is further 
mediated by NarX-NarL and NarQ-NarP (53, 214, 220, 221).    
 
1.8 Role of quinone pool 
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The electron transport system in E. coli has the ability to oxidize a variety of 
substrates and to use different terminal electron acceptors (169).  There are three 
types of electron driven proton pumps.  The first of these is the substrate specific 
dehydrogenases.  This complex carries out the oxidation of organic substrates that 
feeds electrons into a pool of quinones.  NADH dehydrogenase (complex I), 
composed of NDH-1 (nuo) and NDH-II (ndh), and succinate dehydrogenase 
(complex II) make up this first complex in aerobic respiration (93).  Electrons are 
carried from complex I to a pool of quinones (complex III) (81).  Quinones then 
transport electrons to the appropriate terminal oxidoreductases as described above 
(206).   
 
Quinones are lipid-soluble molecules that mediate the transfer of electrons 
between the protein components of the electron transport chain (57, 75).  E. coli 
synthesizes three types of quinones: a benzoquinone, ubiquinone (Q), and two 
napthoquinones, menaquinone (MK) and demethylmenaquinone (DMK) (16-18, 55, 
57-60, 176, 314-316).  The functions of the different quinones have mainly been 
studied through mutant analysis and are discussed below (55, 57-60, 103, 104, 179-
182, 313).  Ubiquinone (Q) is primarily involved in aerobic respiration while 
menaquinone (MK) is involved in nitrate and anaerobic respiration (58, 107, 150, 
151, 180, 192).  A third quinone produced by E. coli, demethylmenaquinone (DMK), 
is mainly involved in anaerobic respiration with acceptors other than nitrate (103, 
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183). Mutants defective in Q (ubiCA and ubiE) and MK/DMK (menA and ubiE) 
biosynthesis have been isolated and characterized (257, 272, 314).   
 
4-Hydroxybenzoate formation from chorismate is the first committed step in Q 
biosynthesis (176).  The reaction is catalyzed by the enzyme chorismate lyase, which 
is encoded by the ubiC gene (16).  In addition, prenylation of 4-hydroxybenzoate is 
carried out by the enzyme 4-hydroxybenzoate octaprenyltransferase, which is 
encoded by the ubiA gene (58, 154, 158).  ubiCA mutants only lack Q and still 
possess both MK and DMK (59).  2-octaprenyl-6-methoxy-1,4-benzoquinol 
methyltransferase (C-methyltransferase), encoded by ubiE, is required for the 
biosynthesis of both ubiquinone and menaquinone (161, 207).  ubiE catalyzes the 
formation of ubiquinone from 4-hydroxybenzoate and menaquinone from 
demethylmenaquinone (180).  Ubiquinone and menaquinone serve as the redox 
mediator in aerobic and nitrate respiration, where ubiE mutants lack both Q and MK 
but retain DMK (296).  Demethylmenaquinone is the major electron carrier during 
anaerobic respiration using terminal electron acceptors other than oxygen and nitrate 
(181, 192, 206). Biosynthesis of demethylmenaquinone from 2-succinylbenzoate 
involves the enzyme 4-dihydroxy-2-naphthoate octaprenyltransferase, encoded by 
menA (249).  Additionally, deletion of the menA gene not only prevents DMK 
biosynthesis but also prevents synthesis of MK.  Prior studies have shown that 
fumarate respiration and DMSO respiration specifically require MK (103, 181, 311, 
312), whereas growth studies and measurements of hydrogen-dependent enzyme 
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) mutant show that DMK can support both 
fumarate and DMSO respiration (286, 312). 
 
The relative concentrations of Q, MK, and DMK have been shown to change with 
varying growth conditions (55, 75, 81, 266, 306, 315).  Studies have previously 
shown that aerated cells contain about four or five times more Q than MK and DMK, 
whereas anaerobic cells contain about one-third as much Q as MK and DMK (158).  
The ability of the three quinones to shuttle electrons under different respiratory 
conditions in the electron transport chain can be best explained by their relative 
affinities for the oxidoreductases as discussed in Chapter 4.  The regulation of 
quinone levels is unknown.  However, it is established that an active fnr gene is not 
necessary for the synthesis of MK and DMK (286).   
 
Given that the specific quinones used by E. coli in vivo have never been 
determined, the quinone pool was examined to confirm the results obtained from the 
terminal oxidoreductase studies.  Previous studies have shown all three quinones to 
be present during both aerobic and anaerobic respiration.  Therefore, the specific 
quinones that couple NADH oxidation to aerobic and anaerobic electron acceptors 
during colonization of the mouse intestine requires further investigation so that 
electron flow through the quinone pool can be better understood as addressed in 
Chapter 4 of this dissertation.     
 
1.9 Maltose and glycogen metabolism 
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Successful colonization of a host relies on a bacterium’s ability to utilize available 
nutrients to generate energy and grow.  Furthermore, many microorganisms oxidize 
carbohydrates for their main source of cellular energy.   Recently, studies have shown 
carbohydrate metabolism to contribute to microbial pathogenesis for several different 
human pathogens (121, 135, 156, 177, 189, 190, 244, 245, 282).  In addition, prior 
studies have found that acquisition of complex sugars is essential for mucosal 
pathogens to successfully colonize and infect their hosts (156, 244, 246, 247).  
Together, these findings suggest that utilization of carbohydrates in vivo is essential 
for pathogenic bacteria to cause disease in humans and is further discussed in Chapter 
5 of this dissertation.  In addition, since we had already studied several carbohydrates 
utilized by E. coli in vivo, we decided to turn our attention to maltose and glycogen 
metabolism, where an exogenous supply of complex sugar and endogenous energy 
storage were examined for their contribution to colonization.    
 
The role of maltose and glycogen utilization during E. coli colonization of the 
mammalian large intestine is currently not known.  However, regulation of the mal 
regulon has been studied extensively (22, 60, 61).  The maltodextrin system in E. coli 
is a major paradigm
 
for understanding complex sugar-utilizing systems in
 
bacteria 
(71, 72).  E. coli has several genes that are involved in maltose and maltodextrin 
utilization and transport (28, 29, 37, 69, 240-242).  MalT is the activator of all the mal 
genes (47, 62, 67, 68, 79, 215, 219, 220).  Maltose and maltodextrins are actively 
transported across the cytoplasmic membrane of E. coli via high affinity periplasmic 
binding ABC transport systems (108-110). Transport of maltose is accomplished by 
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the ABC transporter, which is comprised of a maltose binding protein, MalE (54, 76, 
80, 143, 251, 252), and two membrane bound subunits that make up the 
transmembrane pore, MalF and MalG (120, 241, 284).  E. coli also has another 
maltose transporter, malX, that encodes a typical phosphotransferase (PTS) enzyme 
IIBC complex (80, 217).  Maltodextrin transport requires a specific outer membrane 
diffusion
 
porin, LamB (19, 90, 119, 145, 216). This maltoporin serves also as the λ 
phage receptor and is located in the outer membrane (82, 83, 139, 275, 276).  malP 
and malQ encode enzymes for maltodextrin and maltose metabolism, respectively 
(239, 307, 308).  MalQ, amylomaltase, specifically cleaves maltodextrins, and thus 
releases the reducing-end glucose or dextrin (175, 187, 200, 211).  MalP, 
maltodextrin phosphorylase, is responsible for removing
 
the nonreducing glucosyl 
residue to yield
 
α-glucose-1-phosphate (29, 175, 195, 239).  The degradation of 
glycogen produces maltodextrins which are channeled into metabolism by MalQ and 
MalP, where MalQ will release glucose from maltodextrin and MalP will yield 
glucose-1-phosphate from maltodextrins by phosphorolysis.  Uptake and utilization of 
maltose and maltodextrins by E. coli is a model for understanding how 
microorganisms transport and use complex sugars and is the focus of Chapter 5 (189, 
247).     
 
Glycogen is the major form of stored carbon for E. coli as well as many other 
organisms (149, 223, 224).  It serves as a readily metabolized substrate for 
maintaining energy levels in the cell when nutrients become limiting.  The synthesis 
of glycogen occurs when carbon is abundant and a nutrient that is required for growth 
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is limiting (66).  The biosynthesis of glycogen involves two enzymes, glgA and glgS 
(7, 8, 31, 99, 196, 197, 208-210).  Glycogen synthase (encoded by glgA) is involved 
in ADP-dependent synthesis of glycogen and is the only recognized synthetase 
responsible for synthesis of glycogen (29, 87, 112, 153, 208).  Glycogen synthesis is 
affected by overexpression of a growth-phase-regulated, RpoS-dependent gene, glgS 
(28, 29, 32, 70, 95, 114).  However, the role and contribution of GlgS in glycogen 
biosynthesis has not been identified and has only been found to stimulate synthesis of 
glycogen when overexpressed (114, 147). Glycogen degradation involves glycogen 
phosphorylase (encoded by glgP) to form glucose-1-phosphate (29, 317).   
 
Glycogen is a major energy reserve for the cell and more than likely contributes 
significantly to cell survival (55, 148).  Glycogen synthesis and accumulation varies 
with nutrient abundance, whereas glycogen degradation depends on nutrient depletion 
(9).  During periods when the availability of exogenous carbon sources is intermittent, 
glycogen can supply carbon (178).  This feast and famine lifestyle and the importance 
of maltose and glycogen metabolism during colonization are discussed further in 
Chapter 5.  Increasing our understanding of carbohydrate metabolism and transport 
pathways may, therefore, create new insights into similar mechanisms by which other 
pathogens are able to infect hosts. 
 
1.10 Rationale and significance  
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Both pathogenic and commensal strains of E. coli, strains O157:H7 and K-12, are 
able to colonize the mammalian intestinal tract.  E. coli is the predominant facultative 
anaerobe found in the large intestine amongst a population largely dominated by 
obligate anaerobes.  Commensal bacteria present in the intestine, such as E. coli K-
12, play a significant role in that they provide a defensive barrier to invading 
pathogens (157).  E. coli O157:H7, a common pathogen of the large intestine, causes 
both hemorrhagic colitis and hemolytic-uremic syndrome (HUS) that can ultimately 
result in death (42, 43, 101, 221, 281).  Infection with E. coli O157:H7 causes an 
estimated 70,000 diarrheal illnesses per year in the United States (15, 159, 280, 292).  
It is also the most common cause of renal failure in children (14, 166, 222).  
Transmission of E. coli O157:H7 can be through contaminated food, water, or in 
direct contact with infected people or animals (77, 98, 122, 191, 194, 273, 305).  The 
infectious dose is very low, approximately 10 organisms, thus contributing to 
virulence (142).  Since O157:H7 can colonize the intestine, it must be able to compete 
successfully with the existing commensal flora in order to cause disease.  The 
respiratory pathways used by E. coli during colonization of the intestine are currently 
unknown.  Understanding how this organism is able to survive and grow in the 
intestine will add to our knowledge of the GI tract as well as provide insight as to 
how to treat and prevent infection and disease that occur in the microbial rich habitat 
of the gut. 
 
It has been assumed that strictly anaerobic GI bacteria would not require 
respiratory cytochrome oxidases.  However, recent studies have shown that strict 
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anaerobes, such as Bacteroides fragilis, Desulfovibrio gigas and Moorella 
thermoacetica, contain a cytochrome bd oxidase that is advantageous under 
conditions of nanomolar concentrations of oxygen (11, 64, 172).  Furthermore, He et 
al. found oxygen present in low concentrations in the intestine (113).  Together, these 
findings confirm that oxygen is available in the intestine, and furthermore suggest 
that the intestine is indeed microaerobic.  Specifically, that the anaerobic population 
in the intestine can tolerate and even use very low levels of oxygen.  The facultative 
anaerobes may be responsible for lowering oxygen in the intestine to levels that are 
tolerated by the anaerobes.  This possibility has not been tested in vivo. 
 
Since most mucosal pathogens are facultative anaerobes, our conclusions may be 
extended to include other mucosal pathogens.  In support of this idea, cytochrome bd 
oxidase and nitrate transport were both found to be required for adaptation of 
Mycobacterium tuberculosis to host immunity during chronic infection in mouse lung 
(248).  Likewise, cytochrome bd expression was also found to be required for the 
intracellular survival and virulence of Shigella flexneri in vitro and in mouse 
infections (301).  These examples demonstrate the importance of respiration during 
infection by these mucosal pathogens and support the idea that oxygen stimulates 
infectious disease by providing a competitive advantage for pathogens. 
 
The ability of pathogens to generate energy is essential to their success, growth, 
and persistence in the host.  Understanding the respiratory metabolism of pathogenic 
microorganisms opens a new field of pathogenesis: how energy metabolism 
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contributes to colonization of mucosal surfaces.  These studies may yield novel and 




Although it has never been tested, the availability of different electron acceptors 
in the gut should enable E. coli to respire either aerobically or anaerobically.  
Respiration plays an important role in energy generation in E. coli.  Therefore, I 
hypothesize that respiratory metabolism is important for E. coli to colonize the 
mammalian gastrointestinal tract.  A systematic mutational approach was used to 
examine which respiratory oxidoreductases are important for colonization.  In 
addition, to complete our understanding of the respiratory pathways used in vivo, we 
determined the hierarchy of electron acceptors used by E. coli to colonize the mouse 
intestine as well as the quinones needed to support intestinal colonization.  
Ultimately, the identification of the respiratory pathways used by E. coli in vivo will 
contribute to and improve our understanding of the mammalian GI tract which was 
once presumed to be anaerobic.  Furthermore, comparison of the behavior of 
pathogenic and commensal strains in the mouse intestine will increase and enhance 
















The intestinal microflora is dominated by diverse anaerobes, providing both a 
health benefit to the host (78) and a barrier to infection (89, 115).  Despite being 
present in substantially lower numbers, facultative anaerobes, primarily Escherichia 
coli and Enterococcus faecalis, are ubiquitous in mammalian intestines (234).  While 
the intestine is commonly thought to be anaerobic (6), the tissues surrounding the 
lumen are oxygen-rich and oxygen diffuses into the intestine at appreciable levels 
(113).  Furthermore, oxygen from swallowed air is present in flatus (165).  Oxygen in 
the intestine apparently has minimal impact on persistence of anaerobes and it was 
recently shown that at least one predominant anaerobe, Bacteroides fragilis, respires 
oxygen at low concentrations (11).  In contrast to obligate anaerobes, facultative 
anaerobes (e.g., E. coli) grow most rapidly when respiring oxygen and switch to 
anaerobic respiration in the absence of oxygen or to fermentation in the absence of 
alternative electron acceptors (93).  However, the extent to which facultative 
anaerobes utilize oxygen to maximize their growth rate in the intestine is not known.   
 
Nutrients consumed for growth of the microflora are thought primarily to be 
fermentable carbohydrates, the bulk of which are in the form of polysaccharides 
(203).  E. coli colonizes the mouse intestine by growing within the polysaccharide-
rich mucus layer covering the epithelium, but is unable to degrade polysaccharides.  
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Apparently, E. coli consumes the mono- and disaccharides released during 
degradation of mucosal polysaccharides and dietary fiber (39) by polysaccharide 
hydrolase enzymes secreted by members of the anaerobic microflora (48) and perhaps 
host colonic epithelial cells (12).  Recent studies from our laboratory demonstrate that 
seven mucus-derived sugars contribute to E. coli colonization of the mouse intestine, 
suggesting that biochemical flexibility is key to its competitiveness in vivo (39). E. 
coli is nearly equally flexible in its respiratory metabolism (93), but nothing is known 
about the role of bacterial respiration for coupling ATP generation to carbohydrate 
oxidation in vivo. Thus, it is important to test the hypothesis that oxygen respiration 
confers a competitive advantage to E. coli in the intestine. 
 
Enterohemorrhagic E. coli (EHEC) has an infectious dose for humans as low as 
10 microorganisms and, following ingestion, grows rapidly to a population 
approaching a billion bacteria per gram of feces (142).  Since colonization is the first 
step in the infection process, it is crucial to understand how EHEC colonizes the 
intestine because low numbers can survive transport to consumers in foodstuffs such 
as leafy vegetables, which have caused recent outbreaks in the US (202).  It is not 
known how EHEC acquires nutrients and generates energy for growth in vivo. While 
respiration is not a virulence factor per se, our experiments seek to establish the 
fundamental importance of house keeping functions, such as energy metabolism, for 
pathogenesis.  Since most mucosal pathogens are facultative anaerobes, these studies 
of E. coli may be extended to include many diseases.  
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Here we report the results of a systematic mutational analysis designed to identify 
which respiratory pathways contribute to the ability of commensal and pathogenic E. 
coli to colonize the streptomycin-treated mouse intestine.  Our findings lead us to 
conclude that respiration provides an enormous competitive advantage to E. coli in 
vivo.  The results challenge the traditional view that the intestine is strictly anaerobic 
(6).  Instead, we provide evidence that E. coli colonization of the mouse intestine is 
maximized by the ability to respire oxygen. 
 
2.2 Materials and Methods 
 
Bacterial Strains and Growth Conditions. The bacterial strains used in this study 
were derived from E. coli MG1655 Str
r
 (streptomycin-resistant), a K-12 strain (186), 
and E. coli EDL933 Str
r
, the prototypical O157:H7 strain (184).  Cultures were grown 
at 37°C in Luria-Bertani (LB), with gyratory shaking at 250 rpm. Null alleles were 
constructed by using the allelic replacement method of Datsenko and Wanner (65), as 
described previously (39), such that target genes were deleted and replaced with 
kanamycin- or chloramphenicol-resistance cassettes (used as selectable markers in 
mouse colonization assays, as described below). The null allele strains are identified 
in the text by the genes that were deleted; single gene deletions began with the start 
codon and ended with the stop codon, and multiple gene deletions began with the 
start codon of the first gene deleted and ended with the stop codon of the last gene 
deleted.  Strains containing multiple mutations were constructed by sequential allelic 
replacement; the first inserted cassette was removed with FLP recombinase (65), 
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followed by subsequent allelic replacement(s) and removal of the insertion as 
necessary, leaving the selected marker in the last mutation made.  Mutant strains were 
verified by phenotype analysis and DNA sequencing.  The bacterial strains and 
plasmids used in this study are listed in Table A.2.1.  
 
Phenotypic analysis.   MOPS (3-(N-morpholino) propanesulfonic acid) defined 
medium was used to grow cultures for growth curves, as described previously (39).  
Anaerobic cultures were grown in culture tubes filled to the top with N2-sparged 
media, sealed and incubated in Balch tubes.  To test for nitrate or fumarate reductase 
activity, mutant strains were grown anaerobically overnight in MOPS medium with 
glycerol (1.6%) as the carbon source and either 50 mM nitrate or fumarate as the 
electron acceptor.  Cell growth was monitored spectrophotometrically at 600 nm 
(OD600).   
 
HPLC Analysis.  A Dionex DX-500-Microbore system was used with an IonPac 
AS11 column for anion analysis of mucus.  Standards and blanks were analyzed and 
standard curves were developed for a 1 mg sample of cecal mucus.  Mouse cecal 
mucus was isolated from the cecum of CD-1 male mice and lyophilized as described 
previously (295).  Regression coefficients for standard curves were calculated and 
used to demonstrate the linearity of the peak area with respect to concentration. 
 
Mouse Colonization Experiments. The streptomycin-treated mouse model has been 
used extensively to study colonization of the mouse large intestine by E. coli and 
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Salmonella enterica serovar Typhimurium (39, 49, 116, 295).  Briefly, three CD-1 
male mice, six weeks of age, were given drinking water containing streptomycin 
sulfate (5 g/L) for 24 h to remove the existing resident facultative microflora, and 
then starved for food and water for 18 to 24 h. The mice were then fed approximately 
10
5
 colony-forming units (CFU) of both the wild-type and mutant strains in 1 ml of 




 (nalidixic acid 






 was used to distinguish the 
wild-type (reference strain) from the null allele mutants in fecal plate counts.  After 
the bacterial suspension was ingested, food and streptomycin-water were restored and 
fecal plate counts were determined at 5 h, 24 h, and on every other day thereafter for 
15 days.  Fecal samples were homogenized and diluted in 1% tryptone broth and 
plated on MacConkey agar containing either streptomycin (100 µg/ml) and nalidixic 
acid (50 µg/ml) to count the wild-type or streptomycin and kanamycin (40 µg/ml) or 
chloramphenicol (30 µg/ml) to count the null allele mutants.  Each colonization 
experiment was repeated, on separate occasions, and the plotted values (in figures) 
represent the average for 6 mice.  The log10 mean number of CFU per gram of feces ± 
the standard error for each strain in the mice was calculated for each time point.  In all 
experiments, a difference between two strains >10 CFU/g feces was statistically 
significant, i.e., P<0.005 in student t-test (two-tailed with unequal variance).  The 
limit of detection in fecal plate counts was 10
2
 CFU/g feces.  To determine the role of 
strains during the maintenance stage of colonization, mice were colonized for 10 days 
with a mutant strain of E. coli EDL933, starved for food and streptomycin-water 
 33 
overnight, and fed 10
10
 CFU of the wild-type parent strain E. coli EDL933, after 




Colonization assays.  The preferred animal model for measuring the relative fitness 
of two bacterial strains for intestinal colonization is the streptomycin-treated mouse.  
Streptomycin treatment selectively removes facultative anaerobes while leaving the 
anaerobic microflora essentially intact; this opens a previously unavailable niche, 
which can then be colonized by newly introduced microorganisms such as E. coli (45, 
149, 279).  In this model, competing wild-type and mutant strains are fed together to 
mice and their populations are monitored in fecal plate counts.  Previously we showed 
that colonization involves an initiation stage (5 h to 3 days post-feeding) in which 
nutrients are not limiting and the population increases from low to high numbers, and 
a maintenance stage (7 days post-feeding and beyond) in which nutrients are limiting 
and the population persists at a level correlated with the mutant strain’s relative 
fitness for colonization (39).  For this reason the colonization data shown in Table 2.1 
are given for day 1 (initiation) and day 9 (maintenance) of the 15 day long 
experiments.  To compare the bioenergetics of a commensal strain to that of a 
pathogenic strain, each of the respiratory mutations described in this report were 
constructed in E. coli MG1655 (5), derived from the human isolate, E. coli K-12, and 
E. coli EDL933 (194), the prototypical strain of E. coli O157:H7.  Please note that the 
streptomycin-treated mouse serves as a colonization model for EHEC strains, which 
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do not cause disease in CD-1 mice (278).  We found that each of the mutations tested 
in the commensal and pathogenic strains had a nearly identical impact on 
colonization.  For this reason, colonization curves are shown for E. coli EDL933 
experiments only. 
 
ATP synthase is necessary for colonization.  Since respiratory energy conservation 
requires ATP synthase (185), we tested mutants that lack ATPase for their ability to 
compete with the wild-type in the streptomycin-treated mouse colonization model.  
The ATPase mutant constructions deleted the atpA and atpG genes, which encode the 
F1 alpha and gamma subunits, respectively, resulting in strains capable only of 
fermentative energy metabolism (56).  In competition with their respective wild-
types, E. coli EDL933 ∆(atpA-atpG)::cat and E. coli MG1655 ∆(atpA-atpG)::cat 
were eliminated from mice within 5 days (Table 2.1, Fig. 2.1A, Fig. A.2.1A). It is 
formally possible that mutations inadvertently introduced elsewhere on the genome 
caused the observed colonization phenotype.  However, we would argue that this was 
not the case, for the following reasons.  First, each of the allelic replacements 
described here and elsewhere (35, 152, 174, 176) were obtained with a frequency that 
varied less than one order of magnitude.  Second, half of the mutants tested here and 
in similar studies had no colonization defects.  Third, the results were essentially 
identical in two different genetic backgrounds (EDL933 and MG1655).  The failure 
of the ∆(atpA-atpG)::cat mutants to initiate colonization could be due to a general 
inability to grow in the intestine or inability to compete with the wild-type.  To 
distinguish these possibilities, the mutants were fed alone to mice and found to  
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 Mice were fed 10
5
 CFU each of a mutant and its wild-type parent.  Mice were 
transferred to fresh cages every day and feces no older than 24h were assayed every 
other day for 15 days.  At each time point, for each mouse the Log10 CFU/gram of 
feces for the mutant was subtracted from the Log10 CFU/gram of feces for the wild-
type.  The average ± the standard error of the mean of Day 1 and Day 9 data from 6 
mice are shown.  Differences of at least one order of magnitude (10-fold) are in bold 
type; all values shown in bold are statistically significant: P <0.005 (student’s t-test). 
    E. coli EDL933 E. coli MG1655 
Respiratory Enzyme Mutant Day 1 Day 9 Day 1 Day 9 
ATP synthetase ∆(atpA-atpG)  2.7 ± 0.1  5.6 ± 0.1 5.3 ± 0.5 5.9 ± 0.1 
Regulator of aerobic 
genes  
∆arcA  4.7 ± 0.1  5.6 ± 0.2 3.0 ± 0.2 6.5 ± 0.3 
Regulator of anaerobic 
genes 
∆fnr  1.4 ± 0.2  5.6 ± 0.2 1.3 ± 0.1 6.8 ± 0.1 
Cytochrome bo oxidase ∆(cyoA-cyoB)  0.1 ± 0.1  0.4 ± 0.3 0.4 ± 0.1 0.8 ± 0.1 
Cytochrome bd oxidase ∆(cydA-cydB)  2.5 ± 0.1   5.2 ± 0.1  3.8 ± 0.2  5.0 ± 0.1  
Cytochrome bd oxidase 
(assembly) 
∆(cydD-cydC)  2.4 ± 0.1  5.0 ± 0.2 3.3 ± 0.1 6.0 ± 0.2 
Nitrate reductase ∆narG  0.3 ± 0.1  2.0 ± 0.1 0.4 ± 0.2 2.2 ± 0.1 
Nitrate reductase ∆narZ  0.6 ± 0.1  0.1 ± 0.1 0.3 ± 0.1 0.1 ± 0.2  
Periplasmic nitrate 
reductase 
∆(napD-napA)  0.4 ± 0.1  0.1 ± 0.1 0.2 ± 0.1 0.6 ± 0.1 
Nitrate reductases ∆narG, ∆narZ  0.9 ± 0.1  2.3 ± 0.1 0.1 ± 0.1 2.9 ± 0.2 
Nitrate reductases ∆narG, ∆narZ, 
∆(napD-napA) 
 1.3 ± 0.1  3.1 ± 0.1 0.9 ± 0.1 3.8 ± 0.1 













Figure 2.1.  Respiratory mutants exhibited colonization defects in competitive 
colonization assays.  E. coli EDL933 ∆(atpA-atpG) (A) and E. coli EDL933 ∆(cydA-
cydB) (C) mutants were eliminated during competition with wild-type E. coli 





Figure 2.1. ATPase and cytochrome bd oxidase mutants of E. coli EDL933 exhibit 
colonization defects. 
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colonize at wild-type levels (Fig. 2.1B, Fig. A.2.1B).  The ability of the respiratory-
defective mutants to colonize alone indicates that fermentation is sufficient for 
growth of E. coli in the mouse intestine, but oxidative phosphorylation is essential for 
competition with respiratory-competent strains.  This finding led us to consider 
whether one or more modes of respiration are crucial to occupation of intestinal 
niches formed by electron acceptor availability. 
 
Respiration of oxygen is necessary for colonization.  Proof that aerobic respiration 
is essential for colonization by E. coli was obtained by competing mutants lacking the 
high-affinity cytochrome bd oxidase with their respective wild-types.  The ∆(cydA-
cydB)::cat mutant constructions deleted genes encoding both subunits (I and II) of 
cytochrome bd oxidase, as shown previously (100).  The E. coli EDL933 ∆(cydA-
cydB)::cat  and E. coli MG1655 ∆(cydA-cydB)::cat strains were eliminated by day 11 
during competition with their wild-type parents (Table 2.1, Fig. 2.1C, Fig. A.2.1C).  
The fitness defect observed for the ∆(cydA-cydB)::cat strains was not merely a 
growth defect, since the mutants colonized when fed alone to mice (Fig. 2.1D, Fig. 
A.2.1D).  To confirm the requirement for high-affinity oxygen respiration, ∆(cydD-
cydC)::cat mutants, which cannot assemble cytochrome bd oxidase in the membrane 
(205), were tested and found to have similar colonization defects (Table 2.1 and Fig. 
2.2A, Fig. A.2.2A).  The ∆(cydD-cydC)::cat mutants were able to colonize when fed 
to mice alone (Fig. 2.2B, Fig. A.2.2B).  We note that in addition to being required for 
cytochrome bd oxidase assembly, cydDC encodes a glutathione transport system 













Figure 2.2. Cytochrome bd oxidase assembly mutants of E. coli EDL933 exhibited 
colonization defects in competitive colonization assays. (A) E. coli EDL933 ∆(cydD-
cydC) was defective in competition with wild-type E. coli EDL933 (B) but colonized at 




Figure 2.2. Cytochrome bd oxidase assembly mutants of E. coli EDL933 exhibit 
colonization defects. 
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from one of the other phenotypes associated with loss of glutathione uptake.  Since the 
∆(cydA-cydB)::cat and ∆(cydD-cydC)::cat mutants failed to initiate colonization (i.e., 24 
h), it was necessary to determine if they were also defective in the maintenance stage 
(beyond 7 days).  Therefore, mice were pre-colonized (for 10 days) with E. coli EDL933 
∆(cydD-cydC)::cat and then challenged with E. coli EDL933 wild-type; the mutant was 
eliminated by the wild-type in 7 days, confirming that functional cytochrome bd was 
important for maintenance of colonization (Fig. 2.3).   
We examined also the importance of the low-affinity cytochrome bo3 oxidase for 
colonization.  The construction of ∆(cyoA-cyoB)::cat mutants deleted the genes encoding 
subunits I and II of the cytochrome bo3 oxidase, as shown previously (284).  The results 
showed that E. coli EDL933 ∆(cyoA-cyoB)::cat and E. coli MG1655 ∆(cyoA-cyoB)::cat 
strains co-colonized with their respective wild-type parents, indicating that respiration of 
high oxygen levels was not necessary for colonization (Table 2.1 and Fig. A.2.3).  In 
summary, the colonization defects of the cytochrome bd oxidase mutants challenge the 
traditional view that the intestine is anaerobic (6).  Instead, the results support the 
hypothesis that a microaerobic niche is critical for both establishing and maintaining E. 
coli in the intestine.  Thus, a competitive advantage in vivo is conferred on strains that 
respire oxygen. 
Aerobic respiratory control is necessary for colonization.  E. coli governs respiratory 
flexibility via the global regulators ArcA and Fnr.  ArcA is a two-component regulator of 
several hundred genes (171) that responds to the oxidation state of the quinone pool, 













Figure 2.3.  The ∆(cydD-cydC) mutant exhibited a maintenance defect when mice were 
pre-colonized with E. coli EDL933 ∆(cydD-cydC) and challenged with wild-type E. coli 
EDL933 at day 10.  
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Figure 2.3. Cytochrome bd oxidase assembly mutants of E. coli EDL933 
exhibit colonization defects. 
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affinity oxidase, cytochrome bo3 (encoded by cyoABCDE) and the high-affinity oxidase, 
cytochrome bd (encoded by cydAB) is repressed.  Under microaerobic conditions, where 
oxygen scavenging may play an important role for growth and survival, ArcB 
phosphorylates ArcA, which represses the cyoABCDE operon and activates the cydAB 
and cydDC operons (2).   Since the experiments described above indicated the importance 
of cytochrome bd, we reasoned that arcA mutants would have colonization defects.  The 
construction of E. coli EDL933 ∆arcA::cat and E. coli MG1655 ∆arcA::kan deleted the 
gene encoding the response regulator of the ArcAB two component system, as previously 
described (130).  Although ∆arcA mutants colonized when fed alone (Fig. 2.4B and 
A.2.4B), they could not compete with their respective wild-types and were eliminated 
from mice within 3 days (Table 2.1, Fig. 2.4A, A.2.4A).  While it is tempting to speculate 
that the colonization defect of the ∆arcA mutants resulted solely from failure to induce 
cydAB, the pleiotropic phenotype of the ∆arcA strain makes a number of alternative 
explanations possible.  What is clear from this experiment is that appropriate regulation 
of aerobic respiratory genes is necessary for E. coli to be competitive in vivo. 
 
Anaerobic control is necessary for colonization.  Induction of anaerobic processes in E. 
coli is controlled by Fnr, an oxygen-labile transcription factor which activates the 
transcription of hundreds of genes, including genes that encode respiratory pathways for 
nitrate and fumarate (137, 186).  Since induction of anaerobic respiratory pathways 
requires Fnr, we constructed ∆fnr::kan mutants to test the contribution of this global 
regulator during colonization.  The E. coli EDL933 ∆fnr::kan and E. coli MG1655 













Figure 2.4. Aerobic respiratory and anaerobic global regulatory mutants exhibited 
colonization defects in competitive colonization assays. (A) E. coli EDL933 ∆arcA was 
eliminated during competition with wild-type E. coli EDL933, (B) but was able to 
colonize when fed alone. (C) E. coli EDL933 ∆fnr was eliminated during competition 






Figure 2.4. ArcA and Fnr mutants of E. coli EDL933 exhibit colonization defects. 
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colonization (although not as well as the wild-type), and then were eliminated by day 5 
(Table 2.1, Fig. 2.4C, A.2.4C).  The defect was not an inability to grow in the intestine, 
since the ∆fnr::kan mutants colonized when fed alone to mice (Fig. 2.4D and Fig. A. 
2.4D).  Since the ∆fnr::kan mutant exhibits a colonization defect in competition with the 
wild-type, this implies that E. coli experiences conditions in the intestine that are required 
for Fnr function (13), i.e., anaerobic or nearly anaerobic conditions.  Thus, we conclude 
that Fnr-dependent genes contribute to colonization success.  While these results indicate 
that appropriate regulation of anaerobic respiration is important for colonization, the 
specific roles of the alternative pathways were unclear. 
 
Nitrate reductase is necessary for colonization.  To determine which anaerobic 
respiratory pathways were used during colonization, we considered the in vivo role of 
nitrate reduction.  Since E. coli has three systems for nitrate respiration, it was necessary 
to consider strains with mutations that eliminated each one individually and in 
combination (93).  Mutation of the primary nitrate reductase was accomplished by 
deleting narG (264) to create E. coli EDL933 ∆narG::kan and E. coli MG1655 
∆narG::kan.  When ∆narG::kan strains were fed together with their respective parent 
strains, they initiated colonization, but then declined numerically (2.3 logs, P<0.003) 
(Table 2.1, Fig. 2.5A, Fig. A.2.5).  To test the involvement in colonization of the 
secondary nitrate reductase, mutants were constructed which deleted narZ, the phenotype 
of which was described previously (267).  Likewise, the involvement of the periplasmic 
nitrate reductase was tested with a construction that deleted napD and napA, which 














Figure 2.5.  Anaerobic respiration mutants exhibited colonization defects in competitive 
colonization assays.  (A) E. coli EDL933 ∆narG, (B) E. coli EDL933 ∆narG ∆narZ, (C) 
E. coli EDL933 ∆narG ∆narZ ∆napDA, (D) and E. coli EDL933 ∆frdA mutants were 
















Figure 2.5. Alternative terminal reductase mutants of E. coli EDL933 exhibit 
colonization defects. 
 50 
colonization assays, E. coli EDL933 ∆narZ::cat, E. coli MG1655 ∆narZ::cat, E. coli 
EDL933 ∆(napD-napA)::cat and E. coli MG1655 ∆(napD-napA)::cat co-colonized 
with their wild-type parents, indicating that strains with these individual mutations 
had no phenotype in the intestine (Table 2.1 and Fig. A.2.8).   
 
Although the individual ∆narZ::cat and ∆(napD-napA)::cat mutants did not 
exhibit colonization defects, there is reason to believe these gene systems should be 
expressed in the wild-types under the conditions present in the intestine.  First, the 
intestine contains regions that are microaerobic and others that are anaerobic (113), 
yet apparently is sufficiently anaerobic overall for Fnr control to be a factor in success 
of the entire E. coli population (Fig. 2.4).  Second, we measured a concentration of 
2.62 ± 0.21 mM nitrate in mouse cecal mucus (Table 2.2), a concentration which is 
physiologically relevant for controlling expression of the two nitrate-inducible 
systems (284).  Third, E. coli cells isolated from the intestine show both logarithmic 
and stationary phase characteristics (152).  The narZYWV operon that encodes the 
secondary nitrate reductase is not regulated by anaerobiosis or nitrate, but instead is 
RpoS-dependent and induced in stationary phase (40).  The napFDAGHBC operon 
that encodes the periplasmic nitrate reductase is maximally induced at 1 mM nitrate 
and is expressed at one-half of the maximal level at 2.5 mM (284).  Thus, it is 
reasonable to expect that both the periplasmic and secondary nitrate reductases are 
expressed in the intestine.  To investigate the phenotypes of these nitrate reductase 












Table 2.2.  HPLC analysis of biologically relevant anions present in mouse cecal 
mucus. 
 
          Anions                                            Concentration in Mucus (mM) 
          Nitrate                                                    2.62 ± 0.21  
 
          Nitrite                                                          ND 
           
          Chloride                                                  140 ± 0.56 
           
          Sulfate                                                     14.5 ± 0.39 
 
          Fumarate                                                      ND 
 ND = not detected
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∆narZ::cat and ∆narG ∆narZ ∆(napD-napA)::cat mutants.  In colonization assays E. coli 
EDL933 ∆narG ∆narZ::cat and E. coli MG1655 ∆narG ∆narZ::cat mutants declined 3.2 
log units (P<0.000006) relative to the wild-type strain by day 15 (Table 2.1, Fig. 2.5B, 
Fig. A.2.6).  Also, the E. coli EDL933 ∆narG ∆narZ ∆(napD-napA)::cat and E. coli 
MG1655 ∆narG ∆narZ ∆(napD-napA)::cat mutants declined by 5 log units (P<0.000006) 
to populations just above the limit of detection (<10
3
 CFU/g feces) by the conclusion of 
experiments (Table 2.1, Fig. 2.5D, Fig. A.2.7).  The additive effect of the sequential 
nitrate reductase mutations in competition with the wild-type E. coli EDL933 in these 
experiments is statistically significant: between ∆narG::kan and ∆narG ∆narZ::cat 
(P<0.003) and between ∆narG ∆narZ::cat and ∆narG ∆narZ ∆(napD-napA)::cat 
(P<0.004).  From these results, we conclude the primary nitrate reductase plays the larger 
role of the three systems in the mouse intestine.  In contrast, the ∆narZ and ∆(napD-
napA) mutations affected colonization only in the ∆narG background, suggesting a 
synergy, rather than mere redundancy, between the primary nitrate reductase and the 
other two systems (Fig. A.2.9). Apparently, conditions in the intestine signal induction of 
the three nitrate reductase gene systems, which together confer a competitive advantage 
to E. coli. 
 
Fumarate reductase is necessary for colonization.  To test the importance of fumarate 
as an alternative electron acceptor in vivo, we constructed mutants deleted for frdA, 
which are known to inactivate fumarate reductase (258).  E. coli EDL933 ∆frdA::kan and 
E. coli MG1655 ∆frdA::kan mutants were fed together with their respective parent strains 
and found to initiate colonization, but then declined by approximately 4 logs relative to 
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the wild-type (Table 2.1, Fig. 2.5D, Fig. A.2.10).  Thus, fumarate reductase mutants 
competed poorly, indicating that fumarate is used in the intestine as an alternative 
electron acceptor.   Since fumarate was not detected in intestinal mucus (Table 2.2), it 
most likely was generated endogenously, giving rise to succinate as a fermentation 
product during anaerobiosis (238).  
 
Alternative respiratory pathways are not used during colonization. Other alternative 
electron acceptors reduced by E. coli include dimethyl sulfoxide, trimethylamine 
monoxide, and nitrite (93).  The results showed that ∆dmsAB, ∆torCA, and ∆nirBD 
mutants did not have colonization defects in mice (Table A.2.2, Fig. A.2.11, Fig. A.2.12, 
Fig. A.2.13).  These results served to reinforce our previous observation that not all 
mutations cause colonization defects, lending confidence that the observed defects in 
colonization can be attributed specifically to the metabolic lesions being tested (39).  We 
conclude that DMSO and TMAO are not used for colonization, suggesting they are 
unavailable in the intestine.  Nitrite should be present in the intestine as a result of nitrate 
reduction, but nitrite was not detected in intestinal mucus (Table 2.3).  Since nirBD and 
the wild-type strains co-colonized, we conclude that nitrite is not present at levels 
sufficient to provide a growth advantage.  Since E. coli has redundant reductases for 
nitrite, DMSO, and TMAO, we can only conclude that the primary reductases examined 
in this study are not important for intestinal colonization.  Further examination of the 





Figure 2.6 shows a model of the respiratory pathways that are critical for successful 
colonization by both EHEC and commensal E. coli.  The results indicate that the gut is 
not strictly anaerobic because the high-affinity cytochrome bd oxidase is required to 
successfully compete with the wild-type for colonization (Figs. 2.1 and 2.2).  Also, 
anaerobic respiration of nitrate and fumarate is essential for E. coli in vivo (Fig. 2.5).  We 
therefore conclude that success of E. coli in the gastrointestinal tract demands respiratory 
flexibility and use of the best available electron acceptor. The results allow us to deduce 
the intestinal environment as it is perceived by E. coli.  Accordingly, the niches defined 
by mutational analysis of respiratory pathways should correspond with in vivo 
availability of exogenous electron acceptors, i.e., oxygen and nitrate, but not necessarily 
fumarate, which is generated endogenously by sugar degradation via central metabolism.  
These respiratory niches could be open to the entire population, wherein each bacterium 
simultaneously uses both oxygen and nitrate, or individual cells and micro-colonies could 
each use different electron acceptors.  If distinct microaerobic and anaerobic niches were 
to exist in the intestine, then mutants in the respective respiratory pathways would be 
maintained at populations corresponding to availability of the cogent electron acceptor 
when in competition with respiratory-competent wild-types.  However, since the loss of 
the high affinity oxygen, nitrate, or fumarate respiratory pathways leads to the near or 
complete elimination of the entire population in competition with respiratory-competent 
strains (Fig. 2.1C, 2.5C and 2.5D), the data give us reason to think that both aerobic and 












Figure 2.6.  Model of E. coli respiratory pathways.  Respiratory oxidases and 
reductases used by E. coli in vivo are shown in black.  The oxidase not affecting 
colonization is shown in grey.  The environmental conditions affecting the key 
regulators of the genes encoding the oxido-reductases are shown.  Activation is 
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Figure 2.6. Model of E. coli respiratory pathways used in vivo. 
 57 
mutants implies that the intestinal habitat is at one time microaerobic and at another 
time anaerobic.  Indeed, oxygen tension in the intestine may fluctuate due to dynamic 
cycles of oxygen diffusion and respiratory consumption by facultative anaerobes. 
 
Cole (44) postulated that the redundancy of respiratory systems and complexities 
of their regulation readies bacteria for changes in electron acceptor availability:  when 
respiring nitrate E. coli can respond rapidly to the “arrival” of oxygen or cope when 
nitrate is exhausted.  Thus, the physiology, biochemistry, and genetic control of 
respiratory pathways provides flexibility that is thought to be essential for survival in 
a changing environment (44).  It would appear this strategy is singularly important 
during animal colonization.  We summarize these factors in Figure 2.5.  For E. coli to 
colonize the intestine, appropriate aerobic respiratory control (ArcA) and anaerobic 
control (Fnr) is required (Fig. 2.4).  ArcA is most active under microaerobic 
conditions, i.e., oxygen tension 2-15% of air saturation (2), and Fnr is most active 
during transition to anaerobic conditions, i.e., oxygen tension less than 2% of air 
saturation (13).  Whole-animal measurements indicated oxygen tensions in the 2-7% 
air saturation range for the mouse colon (113).  The measured nitrate concentration in 
intestinal mucus (2.6 mM, see results) is near that which results in maximal 
expression of both nitrate reductase systems, i.e., 1 mM for the periplasmic nitrate 
reductase and 7 mM for the primary nitrate reductase (284).  Regulation of the 
periplasmic nitrate reductase genes requires both NarL and NarP (216), while 
regulation of the primary reductase genes requires NarL only (262).  Since NarP 
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exerts its control at low nitrate levels (<4 mM) and NarL control dominates at higher 
nitrate levels (282), and since both the primary and periplasmic nitrate reductases are 
necessary for efficient colonization, this suggests that nitrate availability might 
fluctuate in the intestine.  Thus, if the intestinal oxygen tension fluctuates in the 
anaerobic to microaerobic range and the nitrate concentration fluctuates in the 1-7 
mM range, then cytochrome bd oxidase, the primary nitrate reductase, the periplasmic 
nitrate reductase, and fumarate reductase all will be expressed in vivo.  Indeed, 
regulation of these gene systems is poised to be most responsive to changes in oxygen 
and nitrate availability in these concentration ranges (269).   
 
The inference that oxygen availability fluctuates because it is consumed by 
bacterial respiration suggests the interesting possibility that facultative anaerobes may 
make the intestinal environment more anaerobic.  Indeed, this conclusion is supported 
by previous studies of the effect of streptomycin-treatment on the mouse anaerobic 
microflora, which selectively removes facultative anaerobes, i.e., E. coli, enterococci, 
streptococci, and lactobacilli.  Following administration of streptomycin, populations 
of strict anaerobes, e.g., bifidobacteria and clostridia decreased, while populations of 
so-called “nanaerobes”, e.g., Bacteroides fragilis, which respires oxygen when 
available in low concentrations (11), were unchanged (116).  Thus, comparisons of 
the populations of anaerobes in mice with or without facultative anaerobes present 
supports the hypothesis that oxygen-scavenging facultative anaerobes, e.g., E. coli, 
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promote the stability of the predominantly anaerobic microflora, exemplifying how a 
minor member can have a large impact on an ecosystem.   
 
Despite the apparent competitive advantage gained by oxygen respiration, the E. 




 CFU/g feces, i.e., E. coli represents 
between 1 in 1,000 and 1 in 10,000 bacteria in the intestine.  The nutrient-niche 
hypothesis states that to be successful each species of the intestinal microflora must 
use at least one carbon source better than all other species (89).  Corollary to this 
hypothesis, the population size of any member of the microflora is determined by the 
concentration of its preferred nutrient(s).  The available concentrations of the seven 
sugars that contribute to colonization by E. coli MG1655 are quite low (45, 191).  
Since E. coli does not secrete polysaccharide-degrading enzymes, its preferred 
substrates are most likely provided by anaerobes, which degrade mucosal 
polysaccharides and dietary fiber, and are thought to release the breakdown products 
for use by the host and other microbes (48).  These facts lead to the conclusion that E. 
coli maximizes its growth yield by coupling oxidation of low nutrient concentrations 
to respiration in the intestine.  This may be a general strategy of facultative anaerobes, 
which generally grow well on simple sugars, but do not secrete polysaccharide-
degrading enzymes.  Thus, high-efficiency respiration may ensure the success of 
facultative anaerobes in the intestine, albeit always in lower numbers, by allowing 
them to maximize cell yield on scarce resources.  
 
 60 
Since most mucosal pathogens are facultative anaerobes, our conclusions may 
extend to other mucosal pathogens.  In support of this idea, Mycobacterium 
tuberculosis genes encoding cytochrome bd oxidase and the nitrate transporter were 
induced during mouse lung infection; a cytochrome bd oxidase mutant was attenuated 
during transition to chronic infection in mice (248).  Likewise, Shigella flexneri 
cytochrome bd mutants showed decreased intracellular survival and attenuated 
virulence in mouse infections (301).  These examples demonstrate the importance of 
respiration during infection by particular mucosal pathogens and support the idea that 
oxygen stimulates infectious disease by providing a competitive advantage for 
pathogens.  Since there appears to be no distinction between enterohemorrhagic and 
commensal E. coli with respect to the respiratory pathways used in vivo, we suggest 
caution in targeting respiratory metabolism for combating EHEC infections because 
of potential collateral damage to commensal facultative anaerobes and the resulting 
instability of the intestinal microbiota (89).   
 
In summary, we have shown that E. coli uses both aerobic and anaerobic 
respiratory pathways during colonization, which is an initial stage of intestinal 
infection.  The results presented in this study support the conclusion that the intestine 
is microaerobic and that aerobic bacterial respiration in the intestine is essential for 
competition, and therefore successful colonization.  Apparently, E. coli respires 
oxygen to optimize its reproduction in animals despite the low availability of its 










Escherichia coli has a complex regulatory network that adjusts the respiratory 
system to compete in the mouse intestine to survive a wide variety of growth 
conditions.  Metabolic efficiency under different environmental conditions depends 
on the flexibility of an organism to use electron acceptors that provide the highest 
energy yield.  Some indigenous microbes of the GI tract, such as facultative 
anaerobes, have the ability to generate energy by oxidative phosphorylation.  
Therefore, these microorganisms may occupy habitats in vivo where oxygen offers an 
ecological advantage.  These aerobic habitats may be in close proximity to epithelial 
cells where O2 molecules are thought to pass from the blood through the epithelium to 
the adjacent bacteria.  Facultative anaerobes, such as E. coli, may also play a role in 
creating and maintaining an anaerobic environment that favors the strict anaerobes 
present in the large bowel (232).  The presence of alternative electron acceptors in the 
intestine, which also can be used, may provide stability to the E. coli population if 
oxygen is not consistently available, allowing it to successfully compete in the 
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intestine.  In the last chapter, I showed that E. coli uses oxygen, nitrate and fumarate 
to efficiently colonize the intestine. 
 
A natural inhabitant of the gastrointestinal tract, E.coli serves an important role in 
maintaining a stable and healthy intestinal microbiota.  My focus in this study was to 
determine the preferred order of electron acceptors used by pathogenic E. coli 
O157:H7 and commensal E. coli K-12 strains during colonization of the murine 
intestine.  E. coli’s ability to respire both aerobically and anaerobically using multiple 
electron acceptors allows for successful colonization, thus ensuring its survival.  
Indeed the energy efficiency provided by respiration may contribute to the wide 
spread distribution (i.e., success) of E. coli as commensal inhabitants of the 
mammalian intestine.  Invading pathogens must compete with the resident intestinal 
microflora in order to establish themselves in the densely populated gastrointestinal 
tract.  Enterohemorrhagic E. coli (EHEC), an intestinal pathogen, has a low infectious 
dose and causes severe foodborne illnesses that can result in diarrhea, hemorrhagic 
colitis, and hemolytic uremic syndrome (135, 183). Thus, it is essential to understand 
how EHEC generates energy for growth, since little is known about the role of 
microbial respiration in pathogenesis during colonization.  Furthermore, competition 
for the best available electron acceptors in the intestine ultimately confers a 
competitive advantage to support intestinal colonization. 
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The respiratory metabolism of E. coli in the GI tract had been ignored for years by 
many studying the physiology of this organism.  However, more interest has 
developed recently regarding the ability of this organism to produce energy for 
growth and survival during colonization of the intestine.  Indeed, prior studies have 
shown oxygen to be in the range of 2 to 7 % air saturation in the mouse intestine 
(113).  Studies have also shown anaerobic bacteria that inhabit the intestinal tract to 
respire oxygen at nanomolar concentrations (113).  Our previous findings that oxygen 
offers a competitive advantage for E. coli in vivo support the idea of microaerobic 
habitats in the intestine.  We have previously shown that oxidative phosphorylation 
mediated by cytochrome oxidase, nitrate reductase, and fumarate reductases all 
contribute in varying degrees to colonization.  Of the two cytochrome oxidases, only 
the high affinity, low oxygen tension cytochrome bd oxidase (CydAB and CydDC) is 
essential for competitive fitness in the intestine during growth from low to high 
numbers (initiation) and for persistence (maintenance stage), whereas cytochrome bo3 
(CyoAB) is not important.  Mutations in nitrate reductase or fumarate reductase had 
no affect on initiation, but reduced fitness for competition with the wild-type during 
maintenance.  Thus, success of E. coli in the gastrointestinal tract demands 
respiratory flexibility and use of the best available electron acceptor, i.e., oxygen.   
 
Since E. coli must compete with the intestinal microflora for available resources, 
it will use the best available electron acceptor that yields the highest redox potential, 
thereby maximizing its energetic efficiency.  E. coli has a preferred order for electron 
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acceptors that enables the organism to achieve maximum and efficient energy 
production.  The established hierarchy of terminal electron acceptors used by E. coli 
in vitro is as follows: oxygen is more energetically favorable than nitrate, which is 
favored over fumarate (100, 249).  This preferred order of electron acceptors follows 
the redox potential for the given acceptor where oxygen gives the maximal energy 
(E°΄= + 0.82 V) followed by nitrate (E°΄= + 0.42 V) and fumarate (E°΄= + 0.031 V) 
(132).  The use of these electron acceptors has been extensively studied in vitro (93).  
However, the hierarchy of these electron acceptors used in vivo has never been 
examined.   
 
To compete in the GI tract, E. coli must be able to adapt to a variety of growth 
conditions.  We have shown E. coli to respire aerobically using the high affinity 
cytochrome oxidase, and in the absence of oxygen switch to anaerobic respiration 
using alternative electron acceptors such as nitrate and fumarate.  To address the 
hierarchical use of electron acceptors in the gut, we used a streptomycin-treated 
mouse colonization model.  Our results demonstrate that oxygen is preferred over all 
other terminal electron acceptors in the intestine.  The data agree with our previous 
finding that the gut is not strictly anaerobic and that oxygen scavenging is necessary 
for colonization.  The ability of facultatively anaerobic bacteria, such as E. coli, to 
alter its respiratory metabolism suggests a type of respiratory flexibility that the 
organism demonstrates in the intestine.  These data suggest that the intestine is not 
static, but instead is in a dynamic state with respect to fluctuations in electron 
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acceptor availability.  Here we show the hierarchy of terminal electron acceptors used 
by E. coli in the microaerobic intestine. 
 
3.2 Materials and Methods 
 
Bacterial Strains and Growth Conditions. The bacterial strains used in this study 
were derived from E. coli MG1655 Str
r
 (streptomycin-resistant), a K-12 strain (176), 
and E. coli EDL933 Str
r
, the prototypical O157:H7 strain (184).  Cultures were grown 
at 37°C in Luria-Bertani (LB), with gyratory shaking at 250 rpm. Null alleles were 
constructed by using the allelic replacement method of Datsenko and Wanner (65), as 
described previously (39), such that target genes were deleted and replaced with 
kanamycin- or chloramphenicol-resistance cassettes (used as selectable markers in 
mouse colonization assays, as described below). The null allele strains are identified 
in the text by the genes that were deleted; single gene deletions began with the start 
codon and ended with the stop codon, and multiple gene deletions began with the 
start codon of the first gene deleted and ended with the stop codon of the last gene 
deleted.  Strains containing multiple mutations were constructed by sequential allelic 
replacement; the first inserted cassette was removed with FLP recombinase (65), 
followed by subsequent allelic replacement(s) and removal of the insertion as 
necessary, leaving the selected marker in the last mutation made.  Mutant strains were 
verified by phenotype analysis and DNA sequencing.  The bacterial strains and 
plasmids used in this study are listed in Table A.2.1. 
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Phenotypic analysis.   MOPS (3-(N-morpholino) propanesulfonic acid) defined 
medium was used to grow cultures for growth curves, as described previously (39).  
Anaerobic cultures were grown in culture tubes filled to the top with N2-sparged 
media, sealed and incubated in Balch tubes.  To test for nitrate or fumarate reductase 
activity, mutant strains were grown anaerobically overnight in MOPS medium with 
glycerol (1.6%) as the carbon source and either 50 mM nitrate or fumarate as the 
electron acceptor.  Cell growth was monitored spectrophotometrically at 600 nm 
(OD600).   
 
HPLC Analysis.  Anion analysis of mucus was made using a Dionex DX-500-
Microbore system with an IonPac AS11 column and a NaOH gradient as eluent.  
Standards and blanks were analyzed and standard curves were developed for a 1 
mg/ml sample of cecal mucus.  Mouse cecal mucus was isolated from the cecum of 
CD-1 male mice and lyophilized as described previously (295).  Regression 
coefficients for standard curves were calculated and used to demonstrate the linearity 
of the peak area with respect to concentration. 
 
Mouse Colonization Experiments. The streptomycin-treated mouse model has been 
used extensively to study colonization of the mouse large intestine by E. coli and 
Salmonella enterica serovar Typhimurium (35, 45, 110, 279).  Briefly, three CD-1 
male mice, six weeks of age, were given drinking water containing streptomycin 
sulfate (5 g/L) for 24 h to remove the existing resident facultative microflora, and 
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then starved for food and water for 18 to 24 h. The mice were then fed approximately 
10
5
 colony-forming units (cfu) of both the wild-type and mutant strains in 1 ml of 




 (nalidixic acid 






 was used to distinguish the 
wildtype (reference strain) from the null allele mutants in fecal plate counts.  After 
the bacterial suspension was ingested, food and streptomycin-water were restored and 
fecal plate counts were determined at 5 h, 24 h, and on every other day thereafter for 
15 days.  Fecal samples were homogenized and diluted in 1% tryptone broth and 
plated on MacConkey agar containing either streptomycin (100 µg/ml) and nalidixic 
acid (50 µg/ml) to count the wildtype or streptomycin and kanamycin (40 µg/ml) or 
chloramphenicol (30 µg/ml) to count the null allele mutants.  Each colonization 
experiment was repeated, on separate occasions, and the plotted values (in figures) 
represent the average for 6 mice.  The log10 mean number of CFU per gram of feces ± 
the standard error for each strain in the mice was calculated for each time point.  The 
limit of detection in fecal plate counts was 10
2
 cfu/g feces.  To determine the role of 
strains during the maintenance stage of colonization, mice were colonized for 10 days 
with a mutant strain of E. coli EDL933, starved for food and streptomycin-water 
overnight, and fed 10
10
 CFU of the wild-type parent strain E. coli EDL933, after 





Control of aerobic respiration is essential for colonization.  ArcA (aerobic 
respiratory control) is a global regulator that activates the high-affinity cytochrome bd 
oxidase and represses the low-affinity cytochrome bo3 oxidase under microaerobic 
conditions (2).  Previously we showed that cytochrome bd oxidase and aerobic 
respiratory control were important for intestinal colonization.  To determine whether 
control of aerobic respiration was important for colonization and if ArcA control of 
cytochrome bd was the reason for the observed colonization defect (∆arcA mutant 
versus wild-type) reported in the last chapter, E. coli EDL933 and MG1655 
∆arcA::kan and ∆(cydA-cydB)::cat were fed low at a level of 10
5
 CFU/mouse.  The 
ArcA mutant was unable to initiate or maintain during competition with cytochrome 
bd oxidase mutants (Fig. 3.1A and Fig. A.3.1A).  The observed 6 log difference 
between the two strains suggests that regulation under microaerobic conditions is 
important for competition of E. coli in the intestine.  Since the ∆arcA mutant 
outcompeted the ∆cydAB mutant, we conclude that the observed colonization defect 
of the ∆arcA strain is not limited to the inability of the ∆arcA mutant to activate 
cydAB expression.  This result is in keeping with similar results with transcriptional 
regulator mutants having a large defect in colonization (157).  Thus, the observed 
defect is probably due to altered regulation of many ArcA-dependent genes. 
 
Aerobic respiration is more important than anaerobic respiration for intestinal 
colonization.  To determine if respiration of oxygen is more important than 








Figure 3.1. Aerobic respiratory global regulatory and cytochrome bd oxidase mutants 
exhibit colonization defects in competitive colonization assays. (A) E. coli EDL933 
∆arcA mutants are unable to compete during colonization with EDL933 ∆(cydA-
cydB) mutant strains. (B) E. coli EDL933 ∆(cydA-cydB)::cat mutants are unable to 
compete during colonization with EDL933 ∆(narG)::kan  mutant strains. (C) E. coli 
EDL933 ∆(cydD-cydC)::cat mutants are unable to compete during colonization with 





Figure 3.1. ArcA and cytochrome bd oxidase mutants of E. coli EDL933 
exhibit colonization defects. 
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ability to compete with primary nitrate reductase mutants in the streptomycin-treated 
mouse colonization model.  E. coli EDL933 and MG1655 ∆(cydA-cydB)::cat and 
∆(narG)::kan were fed low at a level of 10
5
 CFU/mouse.  The cytochrome bd oxidase 
mutants were unable to initiate or maintain colonization when competed against the 
primary nitrate reductase mutants (Fig. 3.1B and Fig. A.3.1B).  We previously 
showed that ∆cyd mutants can colonize alone indicating a fitness defect and not a 
growth defect (Chapter 2).  Therefore, cytochrome bd oxidase is more important than 
nitrate reductase for E. coli colonization of the intestine.  To test whether oxygen is 
more important than fumarate for colonization, we competed cytochrome bd oxidase 
mutants with fumarate reductase mutants.  E. coli EDL933 and MG1655 ∆(cydD-
cydC)::cat and ∆(frdA)::kan were fed low at a level of 10
5
 CFU/mouse.  The 
cytochrome bd oxidase mutants were unable to initiate or maintain colonization when 
competed against the fumarate reductase mutants, demonstrating that cytochrome bd 
oxidase is more important than fumarate reductase for E. coli to colonize the mouse 
intestine (Fig. 3.1C and Fig. A.3.1C).  Since mutants lacking anaerobic respiratory 
pathways were found to outcompete mutants lacking aerobic respiratory pathways 
during colonization, we can conclude that oxygen respiration is more important than 
anaerobic respiration of nitrate and fumarate.  Together, these findings imply that 
oxygen respiration is more advantageous for E. coli to colonize the mouse intestine 
compared to anaerobic respiration.  
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The primary nitrate reductase is most important of the three nitrate reductases 
for intestinal colonization.  E. coli has three nitrate reductases (97, 247): a 
cytoplasmic primary nitrate reductase (encoded by narG), a cytoplasmic secondary 
nitrate reductase (encoded by narZ), and a periplasmic nitrate reductase (encoded by 
napA).  We previously determined that the primary nitrate reductase mutant had a 
colonization defect during competition with the wild-type parent as shown in Chapter 
2.  However, no defects were observed for the other nitrate reductases during 
competiton unless they were in a ∆narG background.  To determine if the primary 
nitrate reductase is the most important of the three, we competed a ∆narG mutant 
against mutants lacking the secondary and periplasmic nitrate reductases to determine 
the in vivo hierarchy of the three reductases.  E. coli EDL933and MG1655 
∆(narG)::kan and ∆(narZ)::cat were fed low at a level of 10
5
 CFU/mouse.  Both 
nitrate reductase mutants were able to colonize initially (Fig. 3.2A and Fig. A.3.2A).  
However, by day 3 postfeeding, the ∆narG strain was no longer able to compete 
against the ∆narZ strain.   The primary nitrate reductase had a 3 log separation at day 
3 postfeeding, and a 5 log separation by day 13 postfeeding relative to the secondary 
nitrate reductase.  The observed fitness defect of ∆narG in competition with ∆narZ 
indicates that NarG is more important than NarZ.   
 
Next, we competed the primary nitrate reductase mutant with a mutant lacking the 
periplasmic nitrate reductase.  E. coli EDL933 and MG1655 ∆(narG)::kan and 
∆(napD-napA)::cat were fed low at a level of 10
5










Figure 3.2.  Primary nitrate reductase mutants exhibit colonization defects during 
competitive colonization assays with the secondary and periplasmic nitrate reductase 
mutants. (A) E. coli EDL933 ∆(narG)::kan mutants are unable to compete during 
colonization with EDL933 ∆(narZ)::cat mutant strains. (B) E. coli EDL933 
∆(narG)::kan mutants are unable to compete during colonization with EDL933 




Figure 3.2. Primary nitrate reductase mutants outcompete secondary 
and periplasmic nitrate reductase mutants in E. coli EDL933. 
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mutants were able to colonize initially (Fig.3.2B and Fig. A.3.2B).  The primary 
nitrate reductase mutant had a 3 log separation at day 9 postfeeding, and a 4 log 
separation by day 15 postfeeding relative to the secondary nitrate reductase.  Again, 
the fitness defect observed for ∆narG in competition with ∆napDA suggests that 
NarG is more important than NapDA.  Thus, the in vivo hierarchy for nitrate 
reductase is consistent with the previous finding that the primary nitrate reductase 
(NarG) is optimally expressed at nitrate levels greater than 2 mM in vitro and 
indicates that the largest flux of electrons to nitrate is through the primary nitrate 
reductase (300).  We have previously measured nitrate in intestinal mucus and found 
nitrate to be present at the 2.62 mM range.  Indeed, our finding nitrate at this 
concentration in cecal mucus agrees with the colonization data for the expression of 
NarG, where the nitrate level is high enough to make NarG the primary nitrate 
reductase used in vivo.  In other words, the primary nitrate reductase is optimally 
expressed in cecal mucus since the nitrate concentration is >2mM.  Thus, NarG is 
preferred over the other two nitrate reductase during intestinal colonization.   
 
Respiration of nitrate is more important than respiration of fumarate for 
intestinal colonization.  To determine the preferred order of alternative electron 
acceptors used for colonization of the mouse intestine, we competed a mutant in the 
primary and secondary nitrate reductases with a fumarate reductase mutant.  E. coli 
EDL933 ∆narG ∆narZ::cat and ∆(frdA)::kan were fed together to mice at a level of 
10
5










Figure 3.3. Nitrate reductase mutant is outcompeted by a fumarate reductase mutant 
in maintenance not initiation during competitive colonization.  E. coli EDL933 
∆narG ∆narZ::cat mutants are unable to compete initially during colonization with 






Figure 3.3. Fumarate reductase mutant outcompetes a nitrate reductase mutant of 
E. coli EDL933 in initiation but not maintenance. 
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by day 4 postfeeding the ∆narGnarZ mutants were able to grow up and subsequently 
outcompete the ∆frdA mutants, which declined by 3 logs relative to the ∆narGnarZ 
strains (Fig. 3.3 and Fig. A.3.3).  This suggests that nitrate is being used as the 
primary anaerobic electron acceptor initially, and when nitrate is no longer readily 
available in the intestine, fumarate is used as an alternative electron acceptor.  These 
results are consistent with the finding that nitrate represses the synthesis of fumarate 
reductase at concentrations greater than 2 mM (130, 133, 284).  Again, this 
concentration of nitrate supports induction of narG and represses frdA (134, 159, 
249).   
 
Since nitrate and fumarate reductase mutants are able to initiate colonization and 
have colonization defects only during maintenance, we decided to focus our attention 
on the maintenance stage of colonization.  We competed either the double nitrate 
reductase mutant or the fumarate reductase mutant with the wild-type EDL933 parent 
strain during maintenance to determine the in vivo hierarchy of nitrate and fumarate.  
E. coli EDL933 ∆narG ∆narZ::cat was fed low at a level of 10
5
 CFU/mouse and then 
challenged with wild-type EDL933 after 10 days postfeeding.  In a similar 
experiment, E. coli EDL933 ∆(frdA)::kan was fed low at a level of 10
5
 CFU/mouse 
and then challenged with wild-type EDL933 after 10 days postfeeding.  In both cases, 
the mutant strains were unable to compete effectively once challenged with high 
levels of the wild-type parent strain and declined in numbers to a 3 and 5 log 










Figure 3.4.  Nitrate and fumarate reductase mutants exhibit colonization defects in 
maintenance during competition with wild-type E. coli. (A) E. coli EDL933 ∆narG 
∆narZ::cat mutant is unable to compete during maintenance with wild-type EDL933 
mutant strains. (B) E. coli EDL933 ∆(frdA)::kan mutant is unable to compete during 




Figure 3.4. Nitrate and fumarate reductase mutants of E. coli EDL933 exhibit 









Figure 3.5.  Nitrate reductase mutants are defective in competition with fumarate 
reductase mutants during maintenance in competitive colonization assays. (A) E. coli 
EDL933 ∆narG ∆narZ::cat pre-colonized mutant is unable to compete during 
maintenance with a E. coli EDL933 ∆(frdA)::kan mutant strain challenged at day 10 
postfeeding. (B) Fig. 4D. E. coli EDL933 ∆(frdA)::kan pre-colonized mutant is able 
to compete during the maintenance stage of colonization with a E. coli EDL933 





Figure 3.5. Nitrate reductase mutants outcompete fumarate reductase mutants of E. 
coli EDL933 when fed high in maintenance. 
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that both nitrate reductase and fumarate reductase are necessary for competition with 
the wild-type during maintenance of intestinal colonization. 
 
To determine the in vivo hierarchy of nitrate and fumarate during maintenance, 
we competed a mutant in the primary and secondary nitrate reductases with a 
fumarate reductase mutant.  E. coli EDL933 ∆narG ∆narZ::cat was fed low at a level 
of 10
5
 CFU/mouse and then challenged with high levels of ∆(frdA)::kan after 10 days 
postfeeding.  The nitrate reductase mutant was unable to maintain colonization after 
the fumarate reductase mutant was introduced (Fig 3.5A).  In this competition, nitrate 
should have been readily available to the fumarate reductase mutant, which can 
respire nitrate.  This result is best explained by the advantage afforded by the ability 
of the fumarate reductase mutant to consume the nitrate that should have been 
available in the animals that were precolonized with the nitrate reductase mutant.  
Therefore, the data suggest that nitrate provided a growth advantage in vivo.  We next 
competed a fumarate reductase mutant against a double nitrate reductase mutant.  E. 
coli EDL933 ∆(frdA)::kan was fed low at a level of 10
5
 CFU/mouse and then 
challenged with high levels of ∆narG ∆narZ::cat after 10 days postfeeding.  The 
fumarate reductase mutant was found to colonize at a steady level prior to introducing 
the nitrate reductase mutant (Fig. 3.5B).  However, the nitrate reductase mutant was 
unable to colonize efficiently in competition with the pre-colonized fumarate 
reductase mutant, showing a 3 log difference and just above detectable levels (2 log 
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cfu/g feces).  These results are consistent with our finding that nitrate is preferred 
over fumarate during the maintenance stage of colonization. 
 
Nitrate analysis of cecal mucus.  To address the availability of nitrate in the mouse 
intestine, we used anion exchange HPLC to determine the concentration of nitrate in 
cecal mucus at day 1, 5, and 11 of colonization.  We previously found nitrate in 
intestinal mucus at a concentration of 2.62 ± 0. 21 mM (Table 2.2).  Similarly, in 
mice colonized with a triple nitrate reductase mutant ∆narG narZ (napD-napA)::cat, 
nitrate was detected in intestinal mucus at levels of 2.76 ± 0.27 mM (day 1), 2.89 ± 
0.33 mM (day 5), 2.65 ± 0.49 mM (day 11) (Table 3.1).  These results agree with the 
nitrate concentrations detected in mucus prepared from uncolonized animals.  By 
comparison, nitrate was undectable in mice colonized with the wild-type EDL933 
strain at day 1, 5, and 11.  The data suggest that E. coli does in fact respire nitrate in 
the intestine and lowers the nitrate to undetectable levels.  Additionally, nitrate 
measurements were conducted for mice co-colonized with ∆narG narZ (napD-
napA)::cat and ∆frdA::kan to determine how the in vivo concentration of nitrate might 
affect competition between the two strains.  Initially, nitrate was found to be 0.77 ± 
0.31 mM (day 1); at this level, nitrate would repress fumarate reductase, explaining 
how the fumarate reductase mutant could outcompete the nitrate reductase mutant 
during the first few days of the experiment.  By day 5 of colonization, nitrate levels 
decreased to 0.31 ± 0.25 mM and were undetectable by day 11.  Together, these 












Table 3.1.  IC analysis of biologically relevant anions present in mouse cecal mucus. 
 
  Strain                            NO3
-
 Concentration in Mucus (mM)            Day of 
Colonization 
  EDL933 Str
R
                                       ND                                                      1 
                                                              ND                                                      5 
                                                              ND                                                     11 
  
  EDL933 Str
R
                                  2.76 ± 0.27                                              1 
   ∆narG narZ(napD-napA)::cat      2.89 ± 0.33                                              5   
                                                         2.65 ± 0.49                                             11 
 
   EDL933 Str
R
                                  0.77 ± 0.31                                             1 
    ∆narG narZ(napD-napA)::cat      0.31 ± 0.25                                             5                                                             
    ∆frdA:: kan                                         ND                                                   11                                                                                 
ND = not detected 
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acceptor until nitrate levels diminish and frdA is no longer repressed, at which time 
the nitrate reductase mutant increases in numbers in the intestine.  Thus, during the 
latter days of the experiment the nitrate reductase mutant has an advantage over the 
∆frdA::kan mutant, which is outcompeted because nitrate levels are too low to 
support its growth in the intestine.  Thus, these results are in agreement with the 
established in vitro hierarchy where nitrate is the more energetically favorable 




We have previously defined the respiratory pathways used by E. coli during 
colonization of the mouse intestine (Chapter 2).  We found the high affinity 
cytochrome oxidase to be essential for colonization in the microaerobic intestine.  We 
also showed nitrate and fumarate reductase to be important in vivo.  The experiments 
described in this study provide evidence that the known hierarchy of electron 
acceptors used by E. coli in vitro (93, 132) also applies during colonization of the 
mouse intestine.  Presumably, the presence of multiple electron acceptors allows E. 
coli to compete in a densely colonized habitat such as the mammalian large intestine, 
where respiratory flexibility and diversity would be an advantage. 
 
 Since prior results demonstrated that aerobic respiration is important for 
colonization and suggested a microaerobic niche for E. coli in the intestine, we 
hypothesized that ArcA was necessary for competition with the wild-type because it 
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is needed to activate cydAB and cydDC (2, 269).  To test this prediction, the arcA and 
cydAB mutants were competed in mice; the cydAB mutant was found to colonize at 
wild-type levels, while the arcA mutant was eliminated by day 3 of the experiment.  
Thus, our results indicate that the defect of strains lacking ArcA is not only due to 
failure to induce cydAB, but may also be caused by inappropriate expression of genes 
and pathways under negative control.  Since ArcA is most active when oxygen is low, 
this result indicates that microaerobic conditions prevail in the intestine, or at least in 
the microhabitats occupied by E. coli.  Furthermore, both ∆narG and ∆frdA mutants 
were found to outcompete the ∆cydAB and ∆cydDC mutants, suggesting that 
respiration of oxygen is more important for colonization than anaerobic respiration.  
Together, these results support previous findings that the intestine is microaerobic 
(138).   
 
Given that E. coli has three nitrate reductase isoenzymes, we were interested to 
determine which of the nitrate reductases was most important.  We found in a direct 
competition that ∆narG could initially colonize but not maintain, while ∆narZ was 
able to initiate and maintain colonization suggesting that NarG is the more important 
nitrate reductase.  In a similar experiment, a ∆napDA mutant was found to 
outcompete the ∆narG mutant, suggesting that the primary nitrate reductase plays a 
significant role in colonization.  These results are consistent with the report that the 
activation of narG requires at least >2 mM nitrate in vitro while activation of 
napFDA requires low levels of nitrate at about 0.5 to 1 mM for maximal expression 
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(251, 284).  Indeed our previous detection of nitrate in intestinal mucus at the level of 
2.62 mM agrees with our observations that NarG plays the primary role for nitrate 
reduction and is necessary for nitrate respiration in vivo.  Therefore, it appears that an 
anaerobic niche exists in the intestine where nitrate is available to signal induction of 
the gene systems necessary for nitrate respiration, which contributes to the 
competitive advantage of E. coli or for the organism that can express NarG, which 
provides the major pathway for electron flow to nitrate.  In contrast, the narZ 
mutation did not affect colonization, suggesting a backup role in vivo for this 
homologous nitrate reductase, which is induced by growth arrest instead of nitrate 
and is regulated by the stationary phase sigma factor, RpoS (40).  Likewise, the 
periplasmic nitrate reductase, NapFDA, had no affect on colonization. 
 
The competition of a nitrate reductase mutant against a fumarate reductase mutant 
revealed that nitrate is used initially in colonization while fumarate is used later 
during maintenance.  Our results are consistent with prior studies that demonstrate 
nitrate repression of fumarate reductase synthesis while activating the synthesis of 
nitrate reductase (48, 92, 201, 202).  Once nitrate levels have diminished, then 
synthesis of fumarate respiratory enzymes is no longer repressed, which would lead 
to the observed result of the competition between fumarate and nitrate reductase 
mutants where fumarate reductase mutants display a colonization defect.  To address 
the role of nitrate in mediating this competition result, we measured nitrate levels in 
mouse cecal mucus colonized simultaneously with ∆narG narZ (napD-napA)::cat and 
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frdA::kan mutants.  Our findings agree with the colonization data in that nitrate levels 
decrease during colonization until nitrate is no longer detectable in the animals.  Once 
nitrate reaches undetectable levels, the fumarate reductase mutant gets outcompeted, 
suggesting that fumarate is the more important electron acceptor in the maintenance 
stage of colonization.  The data also suggest that nitrate is used before fumarate and 
corroborate our previous finding that it is essential for intestinal colonization.  Also, 
we found that wild-type E. coli uses the available nitrate in the intestine, while the 
triple nitrate reductase mutant is unable to.  Since the nitrate level remains high if a 
wild-type E. coli strain is not present, this suggests that E. coli is the primary microbe 
that respires nitrate in the intestine. 
 
Our results show that oxygen respiration is needed for both commensal and 
pathogenic E. coli to compete in the intestine.  We have found cytochrome bd oxidase 
to provide a competitive advantage during competition with other oxidoreductase 
mutants.  Furthermore, nitrate reductase was found to be more important during 
competiton with fumarate reductase up until E. coli respires the available nitrate, 
thereby removing nitrate from the mucus.  Thus, we conclude that the hierarchy of 
terminal electron acceptors used by E. coli in vivo agrees with the in vitro hierarchy.  
Indeed, our previous observation that the entire population of E. coli in the intestine 
depends on both oxygen and nitrate support our finding that this hierarchy holds in 
the intestine.  Therefore, success of E. coli in the lower gastrointestinal tract demands 
respiratory flexibility and use of the best available electron acceptor, in accordance 
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with the strict regulation imposed by oxygen and nitrate.  Together, these experiments 
suggest a hierarchy of electron acceptor utilization in the intestine identical for both 
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Quinones are lipid-soluble molecules that mediate the transfer of electrons 
between the protein components of the electron transport chain, ultimately 
transporting electrons to the appropriate terminal oxidoreductases.  E. coli synthesizes 
three types of quinones: a benzoquinone, ubiquinone, and two napthoquinones, 
menaquinone and demethylmenaquinone (89, 170).  Ubiquinone is presumed to be 
primarily involved in aerobic respiration while menaquinone is thought mainly to be 
involved in nitrate and anaerobic respiration (89, 146, 270, 295).  A third quinone 
produced by E. coli, demethylmenaquinone, is considered to be involved in anaerobic 
respiration using terminal electron acceptors other than nitrate (89, 170, 270).  
However, previous studies have shown all three quinones to be present during both 
aerobic and anaerobic respiration, where only the relative concentrations of the 
quinones changes under varying growth conditions (89, 170).  Given that the exact 
role of the individual quinones used during E. coli respiration remains unknown, our 




We have previously shown that respiration of oxygen is essential for intestinal 
colonization of the murine gastrointestinal tract.  Additionally, respiration of nitrate 
and fumarate were found to be important for colonization during maintenance.  We 
also found that the hierarchy of electron acceptors used in vivo agrees with the 
established in vitro hierarchy, where oxygen is most favored, followed by nitrate and 
fumarate.  To examine the contribution of other electron transport chain components 
for colonization and to corroborate our previous finding that both aerobic and 
anaerobic respiration support colonization, we sought to identify the quinones used in 
vivo.  Using the streptomycin-treated mouse model we performed fitness 
competitions between wild-type E. coli K-12 and O157:H7 strains and mutant strains 
deficient in biosynthesis of various components of the quinone pool.  The 
experiments described in this study confirm the flow of electrons through the 
respiratory pathways used by commensal and pathogenic strains of E. coli to colonize 
the mouse intestine. 
 
4.2 Materials and Methods 
 
Bacterial Strains and Growth Conditions. The bacterial strains used in this study 
were derived from E. coli MG1655 Str
r
 (streptomycin-resistant), a K-12 strain (176), 
and E. coli EDL933 Str
r
, the prototypical O157:H7 (184) strain.  Cultures were grown 
at 37°C in Luria-Bertani (LB), with gyratory shaking at 250 rpm.  The bacterial 
strains and plasmids used in this study are listed in Table A.4.1. 
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Mutant Constructions.  Null alleles were constructed by using the allelic 
replacement method of Datsenko and Wanner (65), as described previously (39), such 
that target genes were deleted and replaced with kanamycin- or chloramphenicol-
resistance cassettes (used as selectable markers in mouse colonization assays, as 
described below). The null allele strains are identified in the text by the genes that 
were deleted; single gene deletions began with the start codon and ended with the 
stop codon, and multiple gene deletions began with the start codon of the first gene 
deleted and ended with the stop codon of the last gene deleted.  Mutant strains were 
verified by phenotype analysis and DNA sequencing. 
 
Mouse Colonization Experiments. The streptomycin-treated mouse model has been 
used extensively to study colonization of the mouse large intestine by E. coli and 
Salmonella enterica serovar Typhimurium (35, 45, 110, 279).  Briefly, three CD-1 
male mice, six weeks of age, were given drinking water containing streptomycin 
sulfate (5 g/L) for 24 h to remove the existing resident facultative microflora, and 
then starved for food and water for 18 to 24 h. The mice were then fed approximately 
10
5
 colony-forming units (cfu) of both the wild-type and mutant strains in 1 ml of 




 (nalidixic acid 






 was used to distinguish the 
wildtype (reference strain) from the null allele mutants in fecal plate counts.  After 
the bacterial suspension was ingested, food and streptomycin-water were restored and 
fecal plate counts were determined at 5 h, 24 h, and on every other day thereafter for 
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15 days.  Fecal samples were homogenized and diluted in 1% tryptone broth and 
plated on MacConkey agar containing either streptomycin (100 µg/ml) and nalidixic 
acid (50 µg/ml) to count the wildtype or streptomycin and kanamycin (40 µg/ml) or 
chloramphenicol (30 µg/ml) to count the null allele mutants.  Each colonization 
experiment was repeated, on separate occasions, and the plotted values (in figures) 
represent the average for 6 mice.  The log10 mean number of CFU per gram of feces ± 
the standard error for each strain in the mice was calculated for each time point.  The 
limit of detection in fecal plate counts was 10
2




Ubiquinone is not necessary for competitive colonization.  The first step in the 
biosynthesis of ubiquinone is the formation of 4-hydroxybenzoate from chorismate 
(Fig. 4.1) (241).  The conversion is mediated by chorismate pyruvate lyase and 4-
hydroxybenzoate octaprenyltransferase encoded by the ubiC and the ubiA genes, 
respectively (154).  Thus, ubiCA mutants make menaquinone and 
demethylmenaquinone, but not ubiquinone.  To determine whether passage of 
electrons through ubiquinone (Q) is required for colonization, we competed ∆(ubiC-
ubiA)::cat mutants with their respective wild-type parent strains in the streptomycin-
treated mouse colonization model.  E. coli EDL933 and MG1655 ∆(ubiC-ubiA)::cat 
were fed low at a level of 10
5



















Figure 4.1. Biosynthetic pathway for Q, DMK, and MK in E. coli.  Number of 
arrows corresponds to number of steps not shown in biosynthetic pathway. 
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DEMETHYLMENAQUINONE 











Figure 4.1. Simplified biosynthetic pathway showing mutational blocks in Q, DMK, 
and MK in E. coli. 
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found to co-colonize with wild-type strains (Table 4.1, Fig. 4.2, Fig. A.4.1).  This 
implies that ubiquinone is not needed to support E. coli colonization of the intestine, 
because menaquinone and demethylmenaquinone are sufficient to carry electrons to 
the appropriate oxidoreductases. 
 
Demethylmenaquinone alone is not sufficient for competitive colonization.  C-
methyltransferase, encoded by ubiE, is required for the biosynthesis of both 
ubiquinone and menaquinone (99, 153, 195).  ubiE catalyzes the formation of 
ubiquinone from 4-hydroxybenzoate and menaquinone from demethylmenaquinone.  
Thus, ubiE mutants can make demethylmenaquinone, but not ubiquinone or 
menaquinone.  Ubiquinone and menaquinone serve as the redox mediator in aerobic 
and nitrate respiration (280, 295).  We tested ∆ubiE::cat mutants for their ability to 
compete with the wild-type strains.  E. coli EDL933 and MG1655 ∆ubiE::cat were 
fed low at a level of 10
5
 CFU/mouse.  The mutants lacking ubiE were unable to 
initiate or maintain colonization when competed against wild-type strains (Table 4.1, 
Fig. 4.3A, Fig. A.4.2).  The fitness defect observed for the ∆ubiE::cat strains was not 
merely a growth defect, since the mutants colonized when fed alone to mice (Fig. 
4.3B).  This result implies that demethylmenaquinone alone is not sufficient and that 
ubiquinone and menaquinone together are necessary for electron transport by E. coli 
during colonization of the intestine.  Given that ubiquinone was found not to be 
necessary for efficient colonization, this implies that menaquinone is most important. 
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    E. coli EDL933 E. coli MG1655 
Quinone Enzyme Mutant Day 1 Day 9 Day 1 Day 9 
Ubiquinone biosynthesis ∆(ubiC-ubiA)  0.2 ± 0.1  0.7 ± 0.1 0.5 ± 0.3 0.4 ± 0.2 
Ubiquinone and 
menaquinone biosynthesis 
∆ubiE  3.3 ± 0.1  5.8 ± 0.1 4.0 ± 0.1 5.7 ± 0.2 
Demethylmenaquinone 
biosynthesis 
∆menA  0.8 ± 0.2  5.4 ± 0.2 0.4 ± 0.2 5.7 ± 0.1 
Demethylmenaquinone and 
RNase E inhibitor  
∆(menA-menG)  0.5 ± 0.1  5.4 ± 0.2 0.1 ± 0.1 5.9 ± 0.1 
RNase E inhibitor (rraA) ∆menG  0.7 ± 0.2  0.3 ± 0.1 0.6 ± 0.1 0.4 ± 0.2 
 
a
 Mice were fed 10
5
 CFU each of a mutant and its wild-type parent.  Mice were 
transferred to fresh cages every day and feces no older than 24h were assayed every 
other day for 15 days.  At each time point, for each mouse the Log10 CFU/gram of 
feces for the mutant was subtracted from the Log10 CFU/gram of feces for the wild-
type.  The average ± the standard error of the mean of Day 1 and Day 9 data from 6 











Figure 4.2.  Ubiquinone mutant co-colonizes with wild-type during competitive 
colonization assays.  E. coli EDL933 ∆(ubiC-ubiA) mutants are able to compete  
with wild-type E. coli EDL933. 
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Figure 4.2.  Mutant defective in ubiquinone synthesis of E. coli EDL933 










Figure 4.3.  Ubiquinone and menaquinone mutants exhibit colonization defects in 
competitive colonization assays.  (A) E. coli EDL933 ∆ubiE mutants are unable to 
compete during initiation and maintenance with wild-type E. coli EDL933. (B) E. coli 
EDL933 ∆ubiE mutants are able to colonize when fed alone to mice.
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Figure 4.3.  Mutants defective in ubiquinone and menaquinone synthesis of E. coli 




Menaquinone and demethylmenquinone are necessary for colonization.  
Biosynthesis of demethylmenaquinone from 2-succinylbenzoate involves the enzyme 
4-dihydroxy-2-naphthoate octaprenyltransferase encoded by menA.  Since 
demethylmenaquinone is a precursor  of menquinone, deletion of the menA gene not 
only prevents DMK biosynthesis, the major electron carrier during anaerobic 
respiration using terminal electron acceptors other that oxygen and nitrate, but also 
prevents synthesis of MK, a major electron carrier during anaerobic respiration of 
nitrate (274).  Thus, to determine the role of anaerobic electron transport pathways 
during colonization, we competed ∆menA mutants with wild-type strains in the 
mouse.  E. coli EDL933 and MG1655 ∆menA::cat were fed low at a level of 10
5
 
CFU/mouse.  The menA mutant was able to initiate, but unable to maintain 
colonization when competed against the wild-type parents (Table 4.1, Fig. 4.4, Fig. 
A.4.3).  Since DMK primarily shuttles electrons to alternative anaerobic electron 
acceptors such as fumarate, DMSO, and TMAO, and since MK shuttles electrons 
primarily to nitrate, our results suggest that nitrate is necessary for competition in the 
mouse intestine during maintenance.  These results confirm the importance of MK in 
intestinal colonization, where DMK plays a minor role to support competitiveness in 
vivo since the ability to initiate colonization is the major difference between the 
∆menA mutant and the ∆ubiE mutant.  Furthermore, Q may also be involved in 










Figure 4.4.  Demethylmenaquinone mutants exhibit colonization defects in 
competitive colonization assays.  (A) E. coli EDL933 ∆menA mutants are unable to 
compete with wild-type E. coli EDL933 during colonization of the mouse intestine. 





Figure 4.4.  Mutant defective in demethylmenaquinone synthesis of E. 
coli EDL933 exhibits colonization defect. 
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menAG is necessary for competitive colonization.  We originally made a ∆(menA-
menG) mutant, not knowing that menG is not involved in menaquinone biosynthesis.  
To verify the role of demethylmenaquinone and menaquinone in vivo, ∆(menA-
menG) and ∆menG mutants were constructed and tested for their relative colonization 
fitness in the mouse intestine.  menG was once thought to be involved in the 
biosynthesis of menaquinone, however, it has been shown more recently to encode 
for a ribonuclease E (RNase E) inhibitor protein (188).  To test the possibility of 
involvement in quinone biosynthesis, E. coli EDL933 and MG1655 ∆(menA-
menG)::cat were fed low at a level of 10
5
 CFU/mouse.  The mutant lacking DMK and 
MK was able to initiate, however unable to maintain colonization during competition 
with the wild-type strains (Table 4.1, Fig. 4.5, Fig. A.4.4).  These results are 
consistent with our observation that DMK and MK are necessary for maintenance 
during E. coli colonization of the mouse intestine.  In a similar experiment, E. coli 
EDL933 and MG1655 ∆menG::cat were fed low at a level of 10
5
 CFU/mouse.  The 
∆menG mutants were found to co-colonize during competition with the wild-type 
strains.  These results confirm prior findings that menG does not encode for 
menaquinone.  Since ∆menAG mutants behave like ∆menA, and ∆menG has no 













Figure 4.5. (A)  E. coli EDL933 ∆(menA-menG)::cat mutant is unable to compete 
during colonization with EDL933 and wild-type strains. (B) E. coli EDL933 and 
∆menG::cat mutants are able to compete during colonization with EDL933 and wild-




Figure 4.5.  Mutant defective in demethylmenaquinone and menaquinone 
biosynthesis and not ribosome synthesis of E. coli EDL933 exhibits a 
colonization defect. 
 109 
We previously found that respiration of low oxygen and nitrate is important for 
colonization based on mutational analysis of terminal oxidoreductases.  We showed 
that colonization of the mouse intestine by E. coli depends upon its ability to use 
oxygen, nitrate, and fumarate as terminal electron acceptors (138).  The mammalian 
intestine is presumed to be anaerobic due to the presence of a large number of 
anaerobes (4); however, there is a lack of evidence to support this theory.  We have 
previously shown cytochrome bd to be important for colonization of the GI tract 
(138).  This suggests that the intestinal environment is not strictly anaerobic, and 
prior studies have found oxygen to be present in the intestinal tract (113).  Moreover, 
we have established that the known hierarchy of electron acceptor utilization, i.e. O2 
> nitrate > fumarate, which was established by investigation of in vitro grown 
cultures is also true in vivo.  However, it was also clear that both aerobic and 
anaerobic processes contribute to successful colonization, most likely in response to 
intermittent availability of oxygen.  To verify these results, we turned to a 
corroborative investigation of the quinone pool.  The results presented in this study 
indicate that MK is the most important for intestinal colonization, followed by Q, 
since a ∆ubiE mutant, which eliminated both Q and MK, is unable to initiate and 
maintain colonization.  DMK alone does not appear to contribute much to 
colonization, as the ∆menA mutant, which eliminated MK and DMK, is able to 
initiate but unable to maintain colonization. 
 
The quinone pool in E. coli consists of three components, including ubiquinone,
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menaquinone, and demethylmenaquinone.  These quinones serve as the electron 
carriers between the appropriate dehydrogenases and oxidoreductases during both 
aerobic and anaerobic respiration.  Q is primarily used under aerobic conditions, 
while MK is used mainly under microaerobic and anaerobic conditions where low 
oxygen and nitrate are available as electron acceptors (280, 289, 294).  Alternatively, 
DMK serves as the major electron carrier during anaerobic respiration of alternative 
electron acceptors such as fumarate (294, 295).  It has been observed that aerated 
cells contain about four or five times more Q than MK and DMK, whereas anaerobic 
cells contain about one-third as much Q as MK and DMK (170, 250).  Biochemically, 
the quinones are used interchangeably to various extents to carry electrons to oxygen 
and alternative electron acceptors, as will be discussed in more detail below.   
 
In order to verify our previous finding that aerobic respiration offers a competitive 
advantage during initiation of intestinal colonization, while anaerobic respiration is 
more important for maintenance, we conducted a systematic mutational analysis of 
quinone biosynthetic genes.  Biosynthetic mutants lacking one or more quinones were 
tested for their ability to colonize the streptomycin-treated mouse model.  Although it 
was not possible to construct strains to distinguish MK from DMK because the two 
mutations that prevented MK synthesis also blocked Q or DMK, we were able to 
separate electron flow through some of the quinones.  Thus, the possible 
combinations eliminated Q and MK or DMK and MK.  A ∆(ubiC-ubiA) mutation 
lacks Q, but contains MK and DMK, a ∆ubiE mutation lacks Q and MK, but contains 
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DMK, and a ∆menA mutation lacks MK and DMK, but contains Q (Table 4.2 and 
Fig. 4.1).  These mutations ultimately allowed us to consider electron flow for the 
∆(ubiC-ubiA) mutation, which is thought to be important under high oxygen tension 
or aerobic conditions, the ∆ubiE mutation important for microaerobic and anaerobic 
conditions using nitrate as a terminal electron acceptor, and the ∆menA mutation 
important for anaerobic respiration of alternative electron acceptors such as nitrate 
and fumarate.  The selectivity of quinones for different terminal oxidoreductases can 
be explained by their binding site affinity.  Binding affinities, demonstrated by Km 
values, have been previously shown for the following: cytochrome bo3 for Q (0.048 
mM), cytochrome bd for Q (0.23 mM), cytochrome bd for MK (1.67 mM), primary 
cytoplasmic nitrate reductase for Q (0.746 mM), primary cytoplasmic nitrate 
reductase for MK (0.916 mM), and fumarate reductase for MK/DMK (0.155 mM) (4, 
33, 34, 96, 111, 173, 174, 225, 230, 255, 256, 304).  The binding affinities, 
determined from steady state kinetic studies, indicate that cytochrome bo3 has the 
highest affinity for Q of all the oxidoreductases, cytochrome bd has a higher affinity 
for Q than MK, and nitrate reductase has similar affinities for both Q and MK.  
However, prior reports suggest that the cytochrome bd oxidase primarily uses MK for 
electron transfer (111).  The enzymology of the anaerobic reductases has only been 
characterized using analogs of the reducing substrate for MK, since MK and DMK 
are very similar structurally and overlap in many instances (225).  Thus, the reported 
affinities for MK can be extended to include DMK.  Since all three quinones are able 
to carry electrons under different respiratory conditions, we can predict the preferred 
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Table 4.2.  Presence or absence of quinones in quinone biosynthetic mutants of E. coli.  N 
(No) indicates absence of quinones in mutant strains and Y (Yes) indicates presence 
of quinones in mutant strains. 
  Quinones Present 
Mutant Q MK DMK 
∆(ubiC-ubiA) N Y Y 
∆ubiE N N Y 
∆menA Y N N 
∆(menA-menG) Y N N 
∆menG Y Y Y 
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use of specific quinones under aerobic and anaerobic conditions.      
   
The pathway used for biosynthesis of all three quinones is shown in Figure 4.1.  
Although Q is used under conditions of high oxygen tension and has been found to be 
present at a higher concentration than both MK and DMK during aerobic respiration 
(89, 170), it has not been proven to be the sole quinone used when oxygen is available 
as a terminal electron acceptor.  We found that a ∆(ubiC-ubiA) mutation, which 
blocks Q biosynthesis only, does not affect colonization of the streptomycin-treated 
mouse.  Additionally, ubiE, involved in biosynthesis of both Q and MK (153), was 
found to have a major colonization defect during competition with the wild-type in 
both initiation and maintenance.  This result suggests that Q is not the only quinone 
utilized by cytochrome bd, and that MK also serves as an electron carrier.   In 
addition, the presence of MK and DMK allows the ∆(ubiC-ubiA) mutant to colonize 
and compete in the mouse intestine, suggesting that both MK and DMK can shuttle 
electrons during aerobic respiration in vivo.  However, DMK alone is unable to serve 
as an electron carrier during intestinal colonization as seen in the ∆ubiE mutant.  In a 
previous study, we found that the high affinity cytochrome bo3 oxidase is not 
important for colonization.  The finding that Q alone is not necessary for colonization 
supports our hypothesis that oxygen tension in the intestine is low because a ∆ubiE 
mutant, lacking both Q and MK, was unable to initiate or maintain colonization.  This 
suggests that both Q and MK shuttle electrons to cytochrome bd oxidase and nitrate 
reductase during colonization and are together important for intestinal colonization.        
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Prior studies have led to the conclusion that Q is required when using oxygen as 
the electron acceptor, although MK has been demonstrated to be used when nitrate 
and other anaerobic electron acceptors are present (89, 170, 256).  In addition, DMK 
has been shown to be present at a higher concentration during anaerobic respiration 
using fumarate, DMSO, or TMAO as an electron acceptor (89, 170).  Our results 
show that a ∆menA mutant, lacking MK and DMK, has a major colonization defect 
during maintenance. This suggests that MK is necessary for intestinal colonization 
since a ∆ubiE mutant, which lacks Q and MK but contains DMK, was unable to 
initiate and maintain colonization.  MK ultimately appears to be suited for carrying 
electrons to a mixture of electron acceptors, such as oxygen and nitrate.  Thus, our 
findings are in accordance with our previous observations that aerobic respiration is 
essential for initiation and maintenance, while anaerobic respiration is essential for 
maintenance.   
 
The specific quinones that couple NADH oxidation to aerobic, microaerobic, and 
anaerobic electron acceptors in vivo requires further investigation so that electron 
flow through the quinone pool can be better understood.  In this study, we sought to 
further our understanding of the respiratory metabolism of E. coli in the intestine by 
using biosynthesis quinone mutants to eliminate electron transfer pathways to verify 
our previous terminal oxidoreductase mutant results.  We have confirmed what we 
have previously learned about the relative importance of terminal oxidoreductases, 
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from what we have discovered here about the contribution of electron flow through 
the quinone pool.  Here we show that the quinones used by both a pathogenic and 
commensal strain during colonization of the mouse intestine are nearly identical, and 
further suggest that the bioenergetics between pathogenic and commensal E. coli in 
the intestine are very similar.  These studies confirm our previous finding regarding 
the respiratory pathways important for E. coli in vivo.  Indeed, our results presented in 
this study support our conclusions that E. coli respires both aerobically and 
anaerobically during colonization of the mouse intestine, specifically that aerobic 
respiration is important during both initiation and maintenance, whereas anaerobic 























Escherichia coli demonstrates remarkable flexibility in the metabolism of 
different sugars as carbon and energy sources (39).  In general, bacterial existence in 
nature is thought to be one of feast and famine since the nutrients that support 
bacterial growth are rarely available continuously and almost always present in 
limiting amounts (146).  It has been suggested that E. coli lives a feast and famine 
type of existence in the mammalian gastrointestinal tract (49).  A feast and famine 
existence in the intestine is supported by the fact that E. coli grows and resides in the 
mucus layer, which despite being rich in carbohydrates and glycoproteins (157), E. 
coli leads a scavenging lifestyle using as many as seven different sugars to support its 
colonization (39).  Apparently, nutrient availability in the intestine is not constant and 
more than likely varies where growth limiting nutrients are limited and variable.  
Thus, times between periods of abundant and limiting nutrients may require that 
intracellular energy stores be used by E. coli to successfully compete and persist in 
the mouse intestine.  Glycogen is the primary carbon and energy storage molecule for 
many bacteria and since glycogen breakdown involves maltose and maltodextrins as 
intermediates, we thought to examine whether catabolism of exogenous maltose and 
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maltodextrins as well as glycogen support intestinal colonization.  The importance of 
maltose utilization and glycogen as a carbon storage molecule, its synthesis and 
degradation, has not been tested in vivo.   
 
Maltose consists of two glucose monosaccharides joined in an α-1-4 linkage, and 
maltodextrins are longer polysaccharides with the same structure. These sugars are 
most commonly derived from starch and glycogen. E. coli can grow on maltose and 
maltodextrins by taking up the sugars and cleaving them to release glucose and 
glucose 1-phosphate.  At least nine genes encode proteins that are involved in the 
utilization of maltose and maltodextrins in E. coli (175). MalT is the maltose 
responsive transcription activator of the maltose system (175).  The maltose inducible 
porin for maltodextrin transport is encoded by lamB and has a larger pore size than 
those of the porins normally present in the outer membrane (297). The periplasmic 
maltose-binding protein that facilitates maltose transport is encoded by malE (103-
105). The transmembrane pore encoded by malF, malG, and malK constitute the 
active transport system for maltose and are located in the inner membrane (103-105). 
malP (maltodextrin phosphorylase) and malQ (amylmaltase) encode enzymes for 
maltodextrin and maltose metabolism, respectively.   
 
Amylomaltase (MalQ) cleaves glucosyl and dextrinyl residues from the 
nonreducing end of incoming or exogenous maltodextrins and transfers them again 
onto glucose and maltodextrins.  In this way, starting with any maltodextrin including 
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maltose, a mixture of maltodextrins and glucose is obtained. Amylomaltase is a strict 
transferase where the total number of glycosidic linkages remains constant during the 
cleavage and transfer reaction. Glucose released by amylomaltase can then enter 
glycolysis after being phosphorylated by glucokinase. The accumulation of 
maltodextrins, however, is prevented by the action of maltodextrin phosphorylase 
encoded by malP. This enzyme phosphorylytically cleaves glucosyl residues from the 
nonreducing end of maltodextrins forming α-glucose 1-phosphate, with maltotetraose 
being the smallest substrate. α-Glucose 1-phosphate then enters glycolysis after 
having been transformed to glucose 6-phosphate by phosphoglucomutase.  Thus, the 
combined action of amylomaltase and maltodextrin phosphorylase yields glucose and 
glucose 1-phosphate from maltodextrin. 
 
In addition to metabolizing carbohydrates for energy production, E. coli can also 
store carbon in the form of glycogen.  Glycogen is a polysaccharide consisting of 
branched polymers that is primarily produced under growth conditions when nutrients 
become limiting (7, 197).  Glycogen is the fundamental energy storage compound for 
most organisms, including bacteria.  However, the importance of glycogen in the 
form of energy storage for E. coli in vivo has never been explored.  Glycogen 
metabolism is encoded by glgA encoding for glycogen synthase, glgS a predicted 
glycogen synthesis protein, and glgP encoding for glycogen degradation (62, 211, 
212).  Glycogen is synthesized during times when carbon is abundant but low 
availability of other nutrients limits growth.  GlgA, glycogen synthase, is responsible 
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for the transfer of a glucosyl unit of ADP-glucose to maltodextrin or glycogen primer 
to form a new α-1,4-glucosidic linkage (153).  GlgS, on the other hand, has no 
defined role in glycogen synthesis except that it is RpoS dependent and its 
overproduction stimulates glycogen synthesis (114).  Glycogen degradation occurs 
when carbon sources become limiting, however, the role of glycogen phosphorylase 
is not well understood (3).  The degradation of glycogen is stimulated during periods 
of substrate deprivation.  GlgP, glycogen phosphorylase, catalyzes glycogen 
breakdown and affects glycogen structure by removing glucose units from the 
polysaccharide outer chain to yield glycogen containing short chains that consist of 
four glucosyl units.  In support of the hypothesis that glycogen metabolism is 
important for colonization, we previously found that one of the genes involved in 
glycogen metabolism, glgS, is highly induced in E. coli K-12, strain MG1655, when 
growing on mucus (39).  
 
We have previously identified the carbon sources utilized by enterohemorrhagic 
E. coli (EHEC) and commensal E. coli K-12 during colonization of the mouse 
intestine and found E. coli to use several monosaccharides during intestinal 
colonization (39).  Sugar usage by E. coli in the mouse intestine has been studied 
extensively in our laboratory.  Genes involved in maltose metabolism were previously 
shown to be induced in E. coli K-12 when growing on intestinal mucus, conditions 
that are thought to mimic nutrient availability in the intestine (39).  Since glycogen 
breakdown involves maltose and maltodextrins as intermediates, we thought to 
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examine whether catabolism of exogenous maltose and maltodextrins as carbon 
sources supports colonization.   
 
In this study, we sought to investigate the role of maltose utilization, glycogen 
storage, and glycogen degradation in vivo.  Here we explore the possible role of a 
feast and famine lifestyle for E. coli in the mouse intestine where maltose utilization 
and the contribution and role of endogenous energy sources for survival inside the 
host was examined.  Our results demonstrate that both maltose and glycogen are 
needed for intestinal colonization.  Furthermore, glycogen synthesis and glycogen 
degradation appear to both be important during colonization.  This suggests that 
endogenous carbon stores might ensure survival during brief periods of carbon 
limitation and success inside the host.  E. coli may experience intermittent nutrient 
starvation when switching carbon sources during infection of animal hosts.  Thus, E. 
coli has more than likely adapted its nutritional preferences in vivo to nutrient 
availability in the host, where carbon storage facilitates its ability to switch to 
available nutrients found in the intestine.  Investigating the use of complex sugars and 
energy storage for colonization will ultimately increase our understanding of nutrient 
utilization in vivo and provide new insight into host-pathogen interactions.   
  
5.2 Materials and Methods 
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Bacterial Strains and Growth Conditions. The bacterial strains used in this study 
were derived from E. coli MG1655 Str
r
 (streptomycin-resistant), a K-12 strain (176), 
and E. coli EDL933 Str
r
, a streptomycin resistant derivative of the prototypical 
O157:H7 strain (184).  Cultures were grown at 37°C in Luria-Bertani (LB), with 
gyratory shaking at 250 rpm.  The bacterial strains and plasmids used in this study are 
listed in Table A.5.1. 
 
Mutant Constructions.  Null alleles were constructed by using the allelic 
replacement method of Datsenko and Wanner (65), as described previously (39), such 
that target genes were deleted and replaced with kanamycin- or chloramphenicol-
resistance cassettes (used as selectable markers in mouse colonization assays, as 
described below). The null allele strains are identified in the text by the genes that 
were deleted; single gene deletions began with the start codon and ended with the 
stop codon, and multiple gene deletions began with the start codon of the first gene 
deleted and ended with the stop codon of the last gene deleted.  Strains containing 
multiple mutations were constructed by sequential allelic replacement; the first 
inserted cassette was removed with FLP recombinase (65), followed by subsequent 
allelic replacement(s) and removal of the insertion as necessary, leaving the selected 
marker in the last mutation made.  Mutant strains were verified by phenotype analysis 
and DNA sequencing.  
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Phenotypic analysis.   MOPS (3-(N-morpholino) propanesulfonic acid) defined 
medium was used to grow cultures for growth curves, as described previously (39).  
To test for the ability to use maltose, mutant strains were grown overnight in MOPS 
medium with maltose (0.2%) supplied as the carbon source.  Cell growth was 
monitored spectrophotometrically at 600 nm (OD600).  Iodine stains were conducted 
to test for the ability of mutant strains to synthesize glycogen.  Strains were grown 
overnight on MOPS medium with 50 mM glucose and flooded with 4 % iodine.  A 
yellow color reaction was the negative determinant for glycogen production, where as 
a brown color reaction was the positive determinant for glycogen production. 
 









 was extracted where glucose (0.2% 
wt/vol) was the sole carbon source.  Culture samples were diluted into DNA-RNA 
Protect (Sierra Diagnostics) to inhibit RNA degradation and the RNA was purified 
using RNeasy minikits with the optional DNase treatment (Qiagen).  The RNA was 
converted to cDNA using Superscript II (Invitrogen) and random hexamers, 
according to the manufacturer’s specifications.  The resulting cDNA was fragmented 
and biotinylated (Enzo Kit, Roche Diagnostics), according to the Affymetrix 
prokaryotic labeling protocol.  Biotinylated samples were hybridized to Affymetrix 
GeneChip custom microarrays for 16 hours at 60°C.  The custom GeneChips 
contained probe sets for all genes on the E. coli MG1655 and E. coli EDL933 
genomes.  Hybridized arrays were stained using the Affymetrix protocol 
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(ProkGE_WS2v2_450).  Biological replicates of cultures were used for all 
microarrays.  After hybridization, microarrays were scanned and .cel files were 
further analyzed.  All biological replicates were averaged after RMA processing 




 grown on glucose were 




 grown on glucose were 
used as the control condition.  Significantly induced genes were binned and identified 
as being greater than 2 standard deviations above the rest of the transcriptome. 
 
Mouse Colonization Experiments. The streptomycin-treated mouse model has been 
used extensively to study colonization of the mouse large intestine by E. coli and 
Salmonella enterica serovar Typhimurium (35, 45, 110, 279).  Briefly, three CD-1 
male mice, six weeks of age, were given drinking water containing streptomycin 
sulfate (5 g/L) for 24 h to remove the existing resident facultative microflora, and 
then starved for food and water for 18 to 24 h. The mice were then fed approximately 
10
5
 colony-forming units (cfu) of both the wild-type and mutant strains in 1 ml of 




 (nalidixic acid 






 was used to distinguish the 
wildtype (reference strain) from the null allele mutants in fecal plate counts.  After 
the bacterial suspension was ingested, food and streptomycin-water were restored and 
fecal plate counts were determined at 5 h, 24 h, and on every other day thereafter for 
15 days.  Fecal samples were homogenized and diluted in 1% tryptone broth and 
plated on MacConkey agar containing either streptomycin (100 µg/ml) and nalidixic 
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acid (50 µg/ml) to count the wildtype or streptomycin and kanamycin (40 µg/ml) or 
chloramphenicol (30 µg/ml) to count the null allele mutants.  Each colonization 
experiment was repeated, on separate occasions, and the plotted values (in figures) 
represent the average for 6 mice.  The log10 mean number of CFU per gram of feces ± 
the standard error for each strain in the mice was calculated for each time point.  The 
limit of detection in fecal plate counts was 10
2




Comparative transcriptomics of E. coli EDL933 to E. coli MG1655 grown in 
glucose.  To colonize the intestine, E. coli EDL933 grows from low to high numbers 
in the presence of E. coli MG1655 (184).  The basis of this competition is thought to 
be nutritional.  Our previous results demonstrated that there are significant nutritional 
differences between E. coli EDL933 and E. coli MG1655 during colonization of the 
mouse intestine (despite having nearly identical nutrient preferences in vitro) (Fabich 
Submitted 2007).  While initial transcriptomics comparisons between E. coli EDL933 
and E. coli MG1655 when grown on mucus compared to glucose revealed minimal 
differences reflecting nutrient availability in mucus, the differences that exist between 
these two strains must have some basis on a gene expression level.  To address any 
differences that might exist between E. coli EDL933 and E. coli MG1655, we 
determined the gene expression profile for these strains during steady-state growth on 
glucose and made a direct comparison in gene expression.  Custom Affymetrix 
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GeneChips show the genes involved in carbohydrate catabolism that were induced in 
glucose-grown E. coli EDL933 (Fig. 5.1).  Genes involved in the transport and 
metabolism of maltose were found to be more upregulated in E. coli EDL933 than E. 
coli MG1655.  Specifically, malE (1.119), malK (1.051), malP (0.781), and malQ 
(0.614) were all induced.  Previously, maltose catabolism genes (malPQ) were also 
shown to be induced in E. coli MG1655 when grown on mucus (39).  Together, these 
findings led us to consider the importance and involvement of maltose uptake and 
utilization during colonization of the mouse intestine. 
 
Maltose transport is necessary for intestinal colonization.  The main focus of this 
study was to investigate the role of an exogenous supply of a complex sugar, such as 
maltose, and its use and metabolism in vivo.  We tested mutants unable to transport 
maltose for their ability to compete with the wild-type in the streptomycin-treated 
mouse colonization model.  Mutants were constructed that deleted the periplasmic 
maltose ABC transport system malE, malF, and malG genes, the phenotype of which 
was described previously as able to grow on maltose (26, 27).  E. coli EDL933 and 
MG1655 ∆(malE-malG)::cat were fed low at a level of 10
5
 CFU/mouse.  During 
competition with the respective wild-types, E. coli EDL933 ∆(malE-malG)::cat and 
E. coli MG1655 ∆(malE-malG)::cat were able to initiate at day 1 post-feeding but 
unable to maintain colonization (Table 5.1, Fig.5.2A, Fig. A.5.1A).  A 4 log 
difference was observed during maintenance, suggesting that maltose transport is 










Figure 5.1.  Maltose genes expressed during steady state growth.  Genes involved in 
carbohydrate catabolism that were induced in glucose-grown E. coli EDL933.  Gene 















































Figure 5.1.  The log2 expression ratio of maltose genes in EDL933 compared to 
MG1655. 
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Table 5.1.  Competitive colonization between maltose and glycogen mutants and 
wild-type E. coli strains. 
a
 
    E. coli EDL933 E. coli MG1655 
Enzyme Mutant Day 1 Day 15 Day 1 Day 15 
Maltose specific 
transport 
∆(malE-malG)  0.4 ± 0.1  3.3 ± 0.2 0.0 ± 0.1 1.3 ± 0.3 
Maltose transport 
PTS system  
∆(malX)  0.4 ± 0.1  0.2 ± 0.2 0.6 ± 0.2 0.6 ± 0.1 
Maltose specific 
and PTS transport 
∆(malE-malG) 
∆malX 




∆(malP-malQ)  0.8 ± 0.1  3.7 ± 0.1 0.8 ± 0.3 4.5 ± 0.3 
Maltodextrin 
phosphorylase 
∆malP  0.3 ± 0.1   1.4 ± 0.5  ND ND 
Amylomaltase ∆malQ  0.3 ± 0.1  3.3 ± 0.4 ND ND 
Maltodextrin 
transport 
∆lamB  0.0 ± 0.2  0.0 ± 0.2 0.0 ± 0.2 0.1 ± 0.2 
Glycogen 
phosphorylase 
∆glgP  0.3 ± 0.1  2.4 ± 0.2 0.5 ± 0.2 3.2 ± 0.1  
Glycogen synthase ∆glgA  0.2 ± 0.1  2.3 ± 0.2 0.2 ± 0.1 2.9 ± 0.2 
Glycogen synthesis ∆glgS  0.2 ± 0.1  1.9 ± 0.1 0.4 ± 0.2 1.6 ± 0.2 
a
 Mice were fed 10
5
 CFU each of a mutant and its wild-type parent.  Mice were 
transferred to fresh cages every day and feces no older than 24h were assayed every 
other day for 15 days.  At each time point, for each mouse the Log10 CFU/gram of 
feces for the mutant was subtracted from the Log10 CFU/gram of feces for the wild-
type.  The average ± the standard error of the mean of Day 1 and Day 9 data from 6 
mice are shown.  Differences of at least one order of magnitude (10-fold) are in bold 
type. 










Figure 5.2.  Mutants in the ATP-dependent ABC transporter of the maltose system 
display colonization defects. (A) E. coli EDL933 ∆(malE-malG) mutants are unable 
to compete during colonization with EDL933 wild-type strains.  However, the PTS 
system of maltose transport exhibits no phenotype in the intestine. (B) E. coli 
EDL933 ∆malX ∆(malE-malG) mutants are unable to compete during colonization 




Figure 5.2.  Maltose transport mutants of E. coli EDL933 exhibit 
colonization defects. 
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maltose in vivo. 
 
Given that E. coli has multiple transporters for maltose, mutants were also 
constructed in the PTS system for maltose transport (malX).  These mutant strains are 
able to grow on maltose, as previously shown (217).  E. coli EDL933 and MG1655 
∆malX::cat mutants were fed low at a level of 10
5
 CFU/mouse with the respective 
wild-type strains.  The mutant strains were found to co-colonize during competition 
with the wild-type parents, suggesting that the maltose PTS transport system is not 
necessary for colonization (Fig. A.5.1B and Fig. A.5.1C).  However, in order to test 
the importance of maltose transport, a double mutant was constructed in both maltose 
uptake systems (malEFG and malX) which eliminated the ability of the strain to 
transport maltose.  E. coli EDL933 and MG1655 ∆(malE-malG) malX::cat mutants 
were fed low at a level of 10
5
 CFU/mouse with wild-types.  The ∆malE-malG 
malX::cat mutants were initially able to colonize but declined in numbers after day 1 
post-feeding (2.5 to 3 log difference) (Table 5.1, Fig. 5.2B, Fig. A.5.1D).  Thus, these 
findings are nearly identical to the ∆(malE-malG)::cat colonizations.  We, therefore, 
conclude from these results that MalX plays a minor role in vivo, whereas MalEFG 
has a more significant role for maltose transport during E. coli colonization. 
 
Maltose catabolism is important for intestinal colonization.  Next we examined 
the importance of maltose utilization during colonization by testing mutants unable to 
metabolize maltose for their ability to compete with the wild-type.  Mutants were 
 132 
constructed that deleted the malP (encoding maltodextrin phosphorylase) and malQ 
(encoding amylmaltase) genes as described previously, where malP mutants are 
unable to grow on maltodextrins and malQ mutants are unable to grow on maltose 
(29).  E. coli EDL933 ∆(malP-malQ)::cat and E. coli MG1655 ∆(malP-malQ)::cat 
were unable to initiate or maintain colonization during competition with the 
respective wild-types (Table 5.1, Fig. 5.3A, Fig. A.5.2).  Initially, a 3 log difference 
was observed during competition that ultimately resulted in a 4 log difference in 
maintenance.  In order to test whether the observed colonization defect was a result of 
the inability of the ∆(malP-malQ)::cat mutants to grow in the intestine or compete 
with the wild-type, mutant strains were fed alone to mice.  Mutants were found to 
colonize the streptomycin-treated mouse at wild-type levels suggesting that the ability 
to utilize maltose, and not the inability of the mutant strain to grow, contributes to 
successful competition in the mouse intestine (Fig. 5.3B).  Thus, the inability of the 
∆(malP-malQ)::cat mutants to initiate colonization is a result of their inability to 
compete with the wild-type.  Our results suggest that maltose catabolism is indeed 
important for E. coli colonization of the intestine.   
 
To determine if the utilization of maltose or maltodextrin caused the malPQ strain 
to have a colonization defect, we further characterized the strain in vivo by deleting 
the gene encoding for either maltodextrin phosphorylase (malP) or amylmaltase 
(malQ) as previously described (27, 226, 228) and testing their ability to compete 












Figure 5.3.  Utilization of maltose and not maltodextrins is essential for competitive 
colonization in the mouse intestine. (A) E. coli EDL933 ∆(malP-malQ) mutants are 
unable to compete during colonization with EDL933 wild-type strains, (B) but is able 
to colonize when fed alone. (C) E. coli EDL933 ∆malQ mutants are unable to 
compete during colonization and display colonization defects during competition with 
EDL933 wild-type strains. (D) E. coli EDL933 ∆malP mutants are able to compete 





Figure 5.3. Maltose utilization mutants of E. coli EDL933 exhibit colonization 
defects.  
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fed with their respective wild-types, they were found to initiate poorly and could not 
maintain colonization as seen by a 4 log colonization defect (Table 5.1 and Fig. 
5.3C).  ∆malP::cat mutants co-colonized with their wild-type parents, indicating that 
maltodextrins are not important for colonization of the intestine (Table 5.1 and Fig. 
5.3D).  These results suggest that the ability to use maltose, but not maltodextrins, is 
important for intestinal colonization.  Thus, from these findings we conclude that 
maltose transport and catabolism are needed to support colonization of the intestine. 
 
Transport of and use of maltodextrin is not necessary for intestinal colonization.  
The malP result suggested that maltodextrin catabolism does not contribute to 
colonization.  To confirm this finding, mutants unable to transport maltodextrins from 
the medium to the cytoplasm were tested for their relative colonization fitness.  
Mutants were constructed to knock out LamB (maltoporin, glycoporin), encoded by 
lamB, a maltodextrin-specific homotrimeric porin found in the outer membrane.  
lamB mutants are unable to grow on maltodextrins as described previously (276).  E. 
coli EDL933 ∆lamB::cat and E. coli MG1655 ∆lamB::cat mutants were fed together 
with the respective parent strains and found to co-colonize (Table 5.1 and Fig. A.5.3).  
From these results, we conclude that transport and catabolism of maltodextrins is not 
important for E. coli to colonize the murine intestinal tract. 
 
Maltose is necessary for EHEC to initiate colonization during competition with 
commensal E. coli.  Since E. coli EDL933 was found to upregulate genes involved in 
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the catabolism and transport of maltose, we wanted to test the importance of maltose 
for the pathogenic strain E. coli EDL933 (EHEC) during competition with the 
commensal E. coli MG1655 strain in the mouse intestine.  If both the pathogen 
EDL933 and commensal strain MG1655 are fed low at 10
5
 CFU/mouse they initiate 
equally well, but the pathogen eventually declines in numbers relative to the 
commensal strain (Fig 5.4A).  Additionally, if the pathogenic strain is fed in low 
numbers and the commensal strain is fed high, then the pathogen is able to initiate 
and outcompete the commensal strain for the first 3 days post-feeding, but then 
declines in numbers relative to the commensal strain as previously shown (Fig. 5.4B) 
(184).  To test the role of maltose catabolism during initiation of E. coli EDL933 in 
the presence of high numbers of wild-type E. coli MG1655, a malQ mutant was 
constructed in E. coli EDL933 and tested for its ability to compete with wild-type E. 
coli MG1655 in the mouse colonization model.  The E. coli EDL933 ∆malQ::cat 
mutant was fed low at 10
5
 CFU/mouse and wild-type MG1655 was fed high at 10
10
 
CFU/mouse.  The results show that the E. coli EDL933 ∆malQ::cat mutant was 
unable to initiate in competition with wild-type E. coli MG1655 during colonization 
(Compare Fig. 5.4B and Fig. 5.4C).  This implies that maltose is important for 
pathogenic E. coli to grow from low to high numbers while attempting to gain 
residence in the mouse intestine when higher numbers of commensal E. coli (i.e., 










Figure 5.4.  Utilization of maltose is necessary for E. coli EDL933 to compete with 
E. coli MG1655 in the mouse intestine. (A) E. coli EDL933 wild-type colonizes 
initially in competition with E. coli MG1655 wild-type when fed low at the same 
level and eventually is eliminated. (B) E. coli EDL933 wild-type is able to colonize 
and outcompete E. coli MG1655 wild-type initially, when E. coli EDL933 is fed low 
and E. coli MG1655 is fed high. (C) A ∆malQ mutant in E. coli EDL933 wild-type is 
unable to initiate colonization during competition with E. coli MG1655 wild-type. 
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Figure 5.4. Maltose utilization mutant of E. coli EDL933 exhibits a 





Glycogen synthesis and degradation are important for colonization and 
competition in the intestine.  To test the involvement of carbon storage during 
colonization in the form of glycogen, mutants were constructed in enzymes encoding 
for glycogen synthesis (glgA and glgS), the phenotypes of which were previously 
described where glgA mutants are unable to synthesize glycogen (108, 185).  E. coli 
EDL933 ∆glgA::cat and E. coli MG1655 ∆glgA::cat were fed low at a level of 10
5
 
CFU/mouse with the wild-type parents.  The mutant strains were able to initiate but 
unable to maintain colonization, ultimately resulting in a 2 log defect (Table 5.1, Fig. 
5.5A, Fig. A.5.4A).  Likewise, E. coli EDL933 ∆glgS::cat and E. coli MG1655 
∆glgS::cat were fed low at a level of 10
5
 CFU/mouse together with the respective 
parent strains.  These mutants also had a 2 log defect in the maintenance stage during 
competition with the wild-type (Table 5.1, Fig. 5.5B, Fig. A.5.4B).  Next we tested 
the importance of glycogen degradation (glgP) in the form of stored energy in the 
mouse intestine.  Mutants were constructed in glgP, which are unable to breakdown 
glycogen, the phenotype of which was described previously (300).  E. coli EDL933 
∆glgP::cat and E. coli MG1655 ∆glgP::cat were fed low at a level of 10
5
 
CFU/mouse.  We found that the glgP mutant could initiate but not maintain 
colonization, marked by a 2 log colonization defect by day 9 post-feeding (Table 5.1, 
Fig. 5.6, Fig. A.5.5).  These results indicate that glycogen is an important carbon store 
used for intestinal colonization and suggest that E. coli encounters times of carbon 
limitation that can be offset by catabolism of glycogen.  To confirm this possibility, 









Figure 5.5.  Glycogen synthesis mutants are unable to effectively compete in the 
mouse intestine. (A) E. coli EDL933 ∆glgA mutants exhibit colonization defects in 
maintenance during competitive colonization with E. coli EDL933 wild-type strains. 
(B) E. coli EDL933 ∆glgS mutants also exhibit colonization defects in maintenance 















Figure 5.6.  Glycogen degradation mutants are unable to compete in the mouse 
intestine. E. coli EDL933 ∆glgP mutants exhibit colonization defects during 
competitive colonization with E. coli EDL933 wild-type. 
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Figure 5.6.  Mutants in glycogen degradation of E. coli EDL933 exhibit 
colonization defects. 
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experiment (Fig. A.5.6).  We previously showed that gluconate, which supports 
growth of E. coli but is not absorbed by the host, is able to affect the outcome of 
experiments that depend on competition for carbon sources (160) and reasoned that 
the constant availability of an excess supply of gluconate would obviate the 
dependence on stored glycogen.  Indeed, the glgP mutant was equally fit for 
colonization in competition with the wild-type parent strain when gluconate was 
supplied in the drinking water.  Thus, this result supports the conclusion that 
glycogen is important for maintaining the highest possible energy levels during times 




In this study, we examined the nutritional role of maltose and glycogen for 
pathogenic and commensal E. coli to colonize the mouse intestine.  Our results show 
that maltose utilization is essential for competitive intestinal colonization, whereas 
glycogen degradation and synthesis is important for competition in the intestine.  
Furthermore, we found that the utilization of maltose in vivo gives EHEC a 
competitive advantage during colonization with the commensal K-12 strain, since the 
inability of EHEC to use maltose as a carbon and energy source eliminated the 
pathogen’s ability to compete effectively in the intestine.  Together, these results 
suggest a role for maltose competition in vivo between pathogenic and commensal 
bacteria.   
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The maltose and maltodextrin systems in E. coli are a model for understanding 
bacterial sugar utilizing systems (27, 67, 68).  Maltose and maltodextrin utilization in 
E. coli is complex.  Extensive work has been done involving the regulatory network 
of the mal operon (67, 68); however, the importance of maltose as a sugar source for 
E. coli has remained an open question (175).  E. coli has several genes that are 
involved in maltose and maltodextrin utilization (175).  We found that genes involved 
in maltose transport and utilization (malQ and malEFG) are necessary for 
colonization.   Conversely, the catabolism and transport of maltodextrins (malP and 
lamB) was found not to be important for colonization of the mouse intestine.   
 
The use of complex sugars for energy storage in the form of glycogen synthesis 
and degradation was used to determine the lifestyle of E. coli in the intestine with 
respect to a feast or famine existence.  The observed 2 log fitness defect of mutants 
unable to degrade or synthesize glycogen during competition in the intestine suggests 
that E. coli experiences intermittent states of nutritional starvation, during which 
stored carbon ensures success and survival in vivo.  Previously we have found E. coli 
to be flexible in its energy yielding capabilities in the form of respiration.  We have 
also found that E. coli is equally flexible in its ability to utilize different sugars as 
carbon sources for energy production and, therefore, successful colonization of its 
host.  E. coli has previously been shown to display a nutritional preference for 
available sugars in vivo.  Indeed, to ensure survival and maximal growth in the 
intestine E. coli has to display flexibility energetically.  
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Successful colonization of a host relies on a bacterium’s ability to utilize available 
nutrients to generate energy and grow.  Many microorganisms oxidize carbohydrates 
for their main source of cellular energy.  Recently, an increased support and 
appreciation of the role of
 
fundamental metabolic processes during bacterial 
pathogenesis has been gained.  Previous studies have shown maltodextrin acquisition 
to be the main factor in the ability of group A Streptococcus (GAS) to successfully 
colonize and infect
 
the oropharynx, which is the major site of GAS infection in 
humans (230-233).  Specifically, the maltodextrin binding protein MalE was found to 
be essential for GAS to colonize
 
the oropharynx.  These
 
findings suggest that maltose 
transport via MalE is a key
 




have shown that deletions
 
in carbon metabolism genes, such as in the 
maltose operon, led
 
to a decreased production of virulence factors
 
including capsular 
polysaccharide and cholera toxin in both S. pneumoniae and Vibrio cholerae (91, 
148).  Additionally, the ability
 
of Mycobacterium tuberculosis to transition to latent 
infection was
 
shown to be affected by the inactivation of isocitrate lyase, an
 
enzyme 
involved in the glyoxylate shunt pathway, further suggesting the importance of 
metabolic genes involved in pathogenesis (167, 178, 179).  Thus,
 
it is reasonable to 
speculate that the utilization of carbohydrates, specifically maltose,
 
may contribute to 
the ability of pathogenic bacteria to cause
 
disease in humans.   
 
Previous reports have also show glycogen reserves to be important for virulence 
and biofilm formation of Salmonella enteritidis (24). However, until recently the 
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relative importance of energy reserves for pathogenic microorganisms has remained 
unknown (178).  In E. coli, glycogen has been found to be involved in extending 
survival during starvation (271).   Bacterial growth rate may certainly vary in the 
intestine, and glycogen stores may supply a temporary source of carbon for cellular 
energy when other sources may be scarce.  Indeed, glycogen was found to be 
important for intestinal colonization of E. coli.  Thus, this suggests that nutrient 
availability is intermittent and the use of carbon stores is important during times of 
transition from one carbon source to the next in the intestine. 
 
In conclusion, we used results of the transcriptome analysis to
 
focus our attention 
on maltose transport and utilization in vivo.  Here we report that the use of a complex 
sugar, as well as stored energy in the form of glycogen, is critical for mucosal 
colonization and competition in the intestine.  Our
 
data further demonstrate that 
malEFG and malQ are essential for E. coli to successfully colonize the intestinal 
tract.  Additionally, glycogen synthesis and degradation are needed to support 
intestinal colonization during times of nutritional transitions for E. coli to successfully 
compete when nutrients are limiting in the intestine.  Our findings, therefore, suggest 
that carbohydrate
 
utilization of maltose (exogenous carbon supply) and carbon 
storage (endogenous carbon supply) both contribute to the ability of pathogens to 
successfully colonize and infect their host. 
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Taken together, these findings open new areas for investigations into bacterial 
colonization and pathogenesis of host mucosal surfaces. The examination of 
understudied areas, such as carbohydrate physiology and their contribution to 
pathogenesis, may yield broadly applicable and novel insights into microbial host-
pathogen
 
interactions and bacterial pathogenesis.   Since the mucosal surface of the 
gastrointestinal tract is a major site
 
of bacterial colonization and infection, further 
investigation into carbohydrate transport, utilization, and the metabolic pathways 
used in vivo is essential for understanding the underlying mechanisms that enable 
pathogens to successfully colonize their hosts.  Furthermore, many of the nutrient 
acquisition mechanisms used by E. coli are also used by other human mucosal 
pathogens.  Therefore, such studies are crucial for understanding pathogenesis and 


























Mammals are aerobes that harbor an intestinal ecosystem dominated by large 
numbers of anaerobic microorganisms.  The role of oxygen in the intestinal 
ecosystem is largely unexplored.  My research provided evidence that aerobic 
respiration is required for commensal and pathogenic E. coli to colonize mice.  A 
systematic mutational analysis was used to determine the role of respiratory 
metabolism in the streptomycin-treated mouse model of intestinal colonization.   Our 
results showed that mutants lacking ATP synthase, which is required for all 
respiratory energy-conserving metabolism, were eliminated by competition with 
respiratory-competent wild-type strains (Table 6.1).  Additionally, mutants lacking 
the high affinity cytochrome bd oxidase, which is used when oxygen tensions are 
low, also failed to colonize (Table 6.2).  However, the low affinity cytochrome bo3 
oxidase, which is used when oxygen tension is high, was found not to be necessary 
for colonization (Table 6.2).  Mutants lacking either nitrate reductase or fumarate 
reductase also had major colonization defects (Table 6.2).  The results showed that 
the entire E. coli population was dependent on both microaerobic and anaerobic 
respiration, consistent with the hypothesis that the E. coli niche is alternately 
microaerobic and anaerobic, rather than static.  Taken together, the results indicate  
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Table 6.1.  Summary of colonization data for respiratory mutants.  Major 





Colonization Defect Phase of Colonization 




 Fnr Regulates anaerobic 
respiration 
Major Maintenance 




Table 6.2.  Summary of colonization data for respiratory oxidoreductase mutants.  





Colonization Defect Phase of Colonization 
 cyoAB Cytochrome bo3 
oxidase 
None   




 narG Nitrate reductase Minor Maintenance 
 narZ Nitrate reductase None   
 napDA Nitrate reductase None   
 narG/narZ Nitrate reductase Significant/Major Maintenance 
 narG/narZ/napDA Nitrate reductase Major Maintenance 
 nirBD Nitrite reductase None   
 frdA Fumarate reductase Major Maintenance 
 dmsAB DMSO reductase None   
 torCA TMAO reductase None   
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that success of the facultative anaerobes in the intestine depends on their respiratory 
flexibility.  Despite competition for relatively scarce carbon sources, the energy 
efficiency provided by respiration may contribute to the wide spread distribution (i.e., 
success) of E. coli as commensal inhabitants of the mammalian intestine. 
 
The availability of terminal electron acceptors in the gastrointestinal tract allows 
Escherichia coli to colonize a densely populated microhabitat.  After establishing 
which respiratory pathways are used by E. coli strains O157:H7 and K-12 to colonize 
the mammalian intestine, i.e., which specific respiratory oxidoreductases are 
important, my next task was to determine the hierarchy of preferred electron 
acceptors used by E. coli in the intestine.  Respiratory pathways were systematically 
eliminated by gene knockouts and the mutants were tested for their relative fitness for 
colonization in the streptomycin-treated mouse.  We determined the relative fitness of 
cytochrome bd mutants in competition with ∆narG::kan and ∆frdA::kan mutants and 
found that oxygen is more important than the alternative electron acceptors nitrate 
and fumarate.  Since E. coli has three nitrate reductases, we tested their relative 
contribution to colonization and found that ∆narG mutants lacking the primary nitrate 
reductase are outcompeted by mutants lacking either NarZ or NapDA, which are the 
secondary cytoplasmic and periplasmic nitrate reductases, respectively.  Next we 
tested the preference for nitrate or fumarate respiration by co-colonizing ∆narG 
narZ::cat and ∆frdA::kan mutants and observed a switch in relative fitness where the 
fumarate reductase mutant outcompeted the nitrate reductase double mutant during 
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initiation, but the fumarate reductase mutant was more competitive during 
maintenance.  The observed switch can best be explained by nitrate availability in the 
intestine, where nitrate represses synthesis of fumarate reductase until nitrate levels 
diminish and fumarate reductase is no longer repressed.  Taken together, the results 
indicate that the in vivo hierarchy of terminal electron acceptors (O2>NO3>fumarate) 
reflects the known regulation of the respective respiratory pathways in vitro.  This 
display of respiratory flexibility during colonization presumably allows E. coli to 
adapt to the availability of electron acceptors present in the intestine, and for the first 
time demonstrates the hierarchy of electron acceptors used in vivo. 
 
The mammalian intestine is presumed to be anaerobic, since the microflora is 
dominated by strict anaerobes.  However, we have showed that cytochrome bd 
oxidase, in addition to nitrate reductase and fumarate reductase, is important for E. 
coli colonization of the gastrointestinal tract.  This suggests that the intestinal 
environment is not strictly anaerobic, but instead contains aerobic microhabitats.  In 
order to complete our understanding of the respiratory pathways used for colonization 
of the mouse intestine, we turned our attention to the intra-membrane electron 
carriers, the quinones.  The E. coli quinone pool consists of ubiquinone (Q), the 
biosynthesis of which is encoded by ubiCA and ubiE, menaquinone (MK), the 
biosynthesis of which is encoded by ubiE, and demethylmenaquinone (DMK) the 
biosynthesis of which is encoded by menA.  These quinones serve as electron carriers 
between the appropriate dehydrogenases and oxidoreductases during both aerobic and 
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anaerobic respiration.  A systematic mutational analysis of quinone pool biosynthetic 
pathways was used to determine the colonization fitness of strains competing in the 
streptomycin-treated mouse model.  We performed fitness competitions with mutant 
strains lacking each of the three quinones in both E. coli K-12 and E. coli O157:H7 
backgrounds. We found that ∆(ubiC-ubiA)::cat mutants co-colonize with the wild-
type parent strain, indicating that Q, which is used primarily during growth when 
oxygen tension is high, is not important for colonization (Table 6.3).  Our results 
show that electron flow under low oxygen tension, which is the primary role of MK, 
is essential for colonization since the ∆ubiE::cat mutant failed to initiate colonization 
in competition with the wild-type and was eliminated from mice (Table 6.3).  In 
addition, electron flow via DMK to alternative anaerobic electron acceptors is 
required for maintenance of colonization, as the ∆menA::cat mutant initiated 
colonization but could not persist in the intestine (Table 6.3).  Together these results 
confirm our previous findings that aerobic respiration of low oxygen is important for 
E. coli to grow from low to high numbers during the initiation stage of colonization 
and that anaerobic respiration is important during the maintenance stage. 
 
It is important to understand how gastrointestinal pathogens
 
acquire the nutrients 
necessary to infect their hosts and initiate
 
the disease process.  Carbohydrate 
utilization has recently been demonstrated to be important for microbial pathogenesis. 
However, the role of complex sugars, such as maltose, and energy storage 
compounds, such as glycogen, during colonization of the mammalian large intestine  
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Table 6.3.  Summary of colonization data for quinone biosynthetic mutants.  Major 





Colonization Defect Phase of Colonization 
 ubiCA Q None   
 ubiE Q/MK Major Initiation, Maintenace 
 menA DMK/MK Major Maintenance 
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is poorly understood.  In this study, we sought to investigate the role of maltose 
utilization, glycogen storage, and glycogen degradation in vivo.  Chapter 5 of this 
dissertation explored the possible role of a feast and famine lifestyle for E. coli in the 
mouse intestine, where the role of endogenous energy sources for survival inside the 
host was examined.  Our results demonstrate that both maltose and glycogen are 
needed for intestinal colonization.  Furthermore, we conclude that bacterial growth 
rate may vary in the intestine, and glycogen stores may supply a steady source of 
carbon for cellular energy when other sources are limiting.  Thus, this further 
suggests that the need for glycogen indicates periods of famine or carbon limitation in 
the intestine.  E. coli almost certainly lives a feast and famine existence during 
infection of animal hosts.  Understanding the use of complex sugars and energy 
storage in vivo should build on our knowledge of model systems such as the one 
discussed here. 
 
In summary, the capacity to respire various terminal electron acceptors provides 
the respiratory flexibility that bacteria need to adapt their energy yielding metabolism 
to changing environmental conditions.  Respiratory flexibility appears to be key to 
maximizing growth yield in vivo.  Respiratory flexibility has been found to be 
important for Mycobacterium tuberculosis, where adaptation of the organism involves 
three respiratory states (248).  Here we provide evidence that respiratory metabolism 
of E. coli O157:H7 and K-12 is critical for successful colonization of the mouse 
intestine.  Furthermore, we showed that the respiratory metabolism of E. coli 
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O157:H7 and E. coli K-12 during colonization of the mouse intestine depends upon 
both aerobic respiration of oxygen and anaerobic respiration of nitrate and fumarate.   
 
While the GI tract is presumed to be an anaerobic environment, our results 
suggest the presence of aerobic microhabitats.  It has been assumed that strictly 
anaerobic GI bacteria would not require respiratory cytochrome oxidases (11).  
However, studies have shown that strict anaerobes, such as Bacteroides fragilis 
Desulfovibrio gigas and Moorella thermoacetica, contain a cytochrome bd oxidase 
that is advantageous under conditions of nanomolar oxygen concentrations (11, 64).  
Together, these findings suggest that the intestine is microaerobic, and indeed He et 
al. (113) found oxygen in low concentrations in the intestine.  Our results further 
indicate that oxygen scavenging may be vital for initiation and maintenance of 
facultative anaerobes and suggests an important role for E. coli in making the GI tract 
anaerobic.  Additionally, it appears that oxygen is important for establishing a high 
population and alternate electron acceptors are important for maintaining 
colonization.  It remains to be determined if the apparent use of these three electron 
acceptors is a property of the entire population, in which each bacterium is using all 
three simultaneously, or if individual cells each use different electron acceptors, 
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Table A.2.1.  Strains and plasmids used in this study.  
 
  Strain or plasmid                          Relevant Characteristic(s)         Source or reference 
MG1655                                         Wild-type (CGSC no. 7740)      E. coli Genetic  
                                                                                                           Stock Culture  
                                                                                                           Collection, Yale  
                                                                                                           University 
MG1655 Str
r
                                   Spontaneous streptomycin-            






                            Spontaneous nalidixic acid-           176 
                                                          resistant mutant of MG1655  






 ∆arcA::kan                arcA deletion mutant of               This study 
                                                          MG1655 Str
r
, carrying km- 




 ∆fnr::kan                   fnr deletion mutant of                   This study 
                                                          MG1655 Str
R
, carrying km- 




 ∆(atpA-atpG)::cat     atpAG deletion mutant of              This study 
                                                          MG1655 Str
r
, carrying cm- 




 ∆(cyoA-cyoB)::cat     cyoAB deletion mutant of              This study 
                                                          MG1655 Str
r
, carrying cm- 




 ∆(cydA-cydB)::cat     cydAB deletion mutant of              This study 
                                                          MG1655 Str
r
, carrying cm- 




 ∆(cydD-cydC)::cat    cydDC deletion mutant of              This study 
                                                          MG1655 Str
r
, carrying cm- 




 ∆narG::kan                narG deletion mutant of                 This study 
                                                          MG1655 Str
r
, carrying km- 
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                                                          resistance cassette 
   
MG1655 Str
r
 ∆narZ::cam                narZ deletion mutant of                  This study 
                                                          MG1655 Str
r
, carrying cm- 
                                                          resistance cassette 
   
MG1655 Str
r
 ∆(napD-napA)::cat    napDA deletion mutant of              This study 
                                                          MG1655 Str
r
, carrying cm- 
                                                          resistance cassette 
   
MG1655 Str
r
 ∆narG narZ::cat        narGnarZ deletion mutant of          This study 
                                                          MG1655 Str
r
, carrying cm- 





                                    narGnarZnapDA deletion mutant    This study 
∆narG naZ(napD-napA)::cat           of MG1655 Str
r
, carrying cm- 




 ∆frdA:: kan                frdA deletion mutant of                    This study 
                                                          MG1655 Str
r
, carrying km- 




 ∆(dmsA-dmsB)::cat   dmsAB deletion mutant of                This study 
                                                          MG1655 Str
r
, carrying cm- 




 ∆(torC-torA)::cat       torCA deletion mutant of                  This study 
                                                          MG1655 Str
r
, carrying cm- 




 ∆(nirB-nirD)::cat      nirBD deletion mutant of                   This study 
                                                          MG1655 Str
r
, carrying cm- 
                                                          resistance cassette 
 




                                    Spontaneous streptomycin-                   174 






                           Spontaneous nalidixic acid-                   
                                                          resistant mutant of EDL933 Str
r  






                            Spontaneous rifampicin-                   This study 
 183 






 ∆arcA::cam                arcA deletion mutant of                    This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆fnr::kan                    fnr deletion mutant of                       This study 
                                                          EDL933 Str
r
, carrying km- 




 ∆(atpA-atpG)::cat      atpAG deletion mutant of                This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆(cyoA-cyoB)::cat     cyoAB deletion mutant of                This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆(cydA-cydB)::cat     cydAB deletion mutant of                This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆(cydD-cydC)::cat     cydDC deletion mutant of               This study 
                                                          EDL933 Str
r
, carrying cm- 
                                                          resistance cassette 
   
EDL933 Str
r
 ∆narG::kan                narG deletion mutant of                  This study 
                                                          EDL933 Str
r
, carrying km- 
                                                          resistance cassette 
   
EDL933 Str
r
 ∆narZ::cam                 narZ deletion mutant of                  This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆(napD-napA)::cat     napDA deletion mutant of                This study 
                                                          MG1655 Str
r
, carrying cm- 




 ∆narG narZ::cat         narGnarZ deletion mutant of          This study 
                                                          EDL933 Str
r
, carrying cm- 
                                                          resistance cassette 
 
EDL933 Str
r                                            
       narGnarZnapDA deletion mutant     This study 
  ∆narG naZ(napD-napA)::cat        of EDL933 Str
r
, carrying cm- 
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 ∆frdA:: kan                 frdA deletion mutant of                     This study 
                                                          EDL933 Str
r
, carrying km- 




 ∆(dmsA-dmsB)::cat    dmsAB deletion mutant of                 This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆(torC-torA)::cat        torCA deletion mutant of                  This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆(nirB-nirD)::cat        nirBD deletion mutant of                  This study 
                                                          EDL933 Str
r
, carrying cm- 
                                                          resistance cassette 
 
pKD3                                             Template plasmid, contains                 61                                                    
                                                          chloramphenicol resistance  
          cassette flanked by FLP  
          recombinase target sites; bla cat 
  
 pKD4                                             Template plasmid, contains                  61 
                                                          kanamycin resistance cassette flanked 
                                                          by FLP recombinase target sites; 
                                                          bla kan 
   
  pKD46                                          Temperature-sensitive plasmid,              61 
                                                          contains arabinose-inducible λ phage  
                                                          red recombinase gene for linear 

















    E. coli EDL933 E. coli MG1655 
Respiratory Enzyme Mutant Day 1 Day 9 Day 1 Day 9 
Dimethyl sulfoxide 
reductase 
∆dmsAB  0.6 ± 0.1  0.3 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 
Trimethylamine N-oxide 
reductase 
∆torCA  0.6 ± 0.1  0.2 ± 0.1 0.1 ± 0.1 0.2 ± 0.1 
Fumarate reductase ∆frdA  0.8 ± 0.1  3.1 ± 0.2 0.1 ± 0.1 2.8 ± 0.2 
a
 Mice were fed 10
5
 CFU each of a mutant and its wild-type parent.  Mice were transferred 
to fresh cages every day and feces no older than 24h were assayed every other day for 15 
days.  At each time point, for each mouse the Log10 CFU/gram of feces for the mutant was 
subtracted from the Log10 CFU/gram of feces for the wild-type.  The average ± the 
standard error of the mean of Day 1 and Day 9 data from 6 mice are shown.  Differences of 
at least one order of magnitude (10-fold) are in bold type; all values shown in bold are 



















Figure A.2.1. Respiratory mutants exhibited colonization defects in competitive 
colonization assays. (A) E. coli MG1655 ATPase mutants showed colonization 
defects during competition with wild-types, (B) but were able to colonize when 
fed alone. (C) E. coli MG1655 cytochrome bd oxidase mutants showed 
colonization defects during competition with wild-types, (D) but were able to 





Figure A.2.1. ATPase and cytochrome bd oxidase mutants of E. coli MG1655 


















Figure A.2.2.  Cytochrome bd oxidase assembly mutants of E. coli EDL933 
exhibited colonization defects in competitive colonization assays. (A) E. coli 
MG1655 ∆(cydD-cydC) mutants showed colonization defects during competition 




Figure A.2.2. Cytochrome bd oxidase assembly mutants of E. coli 




















Figure A.2.3. Cytochrome bo3 oxidase mutants compete with wild-type strains in 
competitive colonization assays. (A) E. coli EDL933 ∆(cyoA-cyoB) mutants co-
colonized and displayed no colonization defect during competition with wild-type 
E. coli EDL933. (B) E. coli MG1655 ∆(cyoA-cyoB) mutants co-colonized and 






















Figure A.2.4.  Aerobic respiratory and anaerobic global regulatory mutants 
exhibit colonization defects in competitive colonization assays. (A) E. coli 
MG1655 ∆arcA was eliminated during competition with wild-type E. coli 
MG1655, (B) but was able to colonize when fed alone. (C) E. coli MG1655 ∆fnr 
was eliminated during competition with wild-type E. coli MG1655, (D) but was 
























Figure A.2.5. Primary nitrate reductase mutants display colonization defects with 
wild-type strains in competitive colonization assays. E. coli MG1655 ∆narG 
mutants are defective in maintenance during competition with wild-type E. coli 
MG1655. 
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Figure A.2.6. Nitrate reductase mutants in the primary and secondary reductase 
display colonization defects in competitive colonization assays. (A) E. coli 
EDL933 ∆narG narZ was defective in competition during maintenance with wild-
type E. coli EDL933, (B) E. coli MG1655 ∆narG narZ was defective in 






















Figure A.2.7. Nitrate reductase mutants in the primary and secondary and 
periplasmic reductase display colonization defects in maintenance during 
competitive colonization assays. (A) E. coli EDL933 ∆narG narZ (napD-napA) 
was defective in competition with wild-type E. coli EDL933, (B) E. coli MG1655 























Figure A.2.8. Nitrate reductase mutants in the secondary reductase are able to 
compete in competitive colonization assays. (A) E. coli EDL933 ∆narZ was able 
to co-colonize during competition with wild-type E. coli EDL933, (B) E. coli 























Figure A.2.9. Nitrate reductase mutants in the periplasmic nitrate reductase are 
able to compete in competitive colonization assays. (A) E. coli EDL933 ∆(napD-
napA) was able to co-colonize during competition with wild-type E. coli EDL933, 
(B) E. coli MG1655 ∆(napD-napA) was able to co-colonize during competition 




Figure A.2.9. E. coli periplasmic nitrate reductase mutants do not 


















Figure A.2.10. Fumarate reductase mutants display colonization defects in 
competitive colonization assays.  E. coli MG1655 ∆frdA was defective in 
maintenance during competition with wild-type E. coli MG1655. 
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Figure A.2.11. DMSO reductase mutants are able to compete in competitive 
colonization assays. (A) E. coli EDL933 ∆(dmsA-dmsB) was able to co-colonize 
during competition with wild-type E. coli EDL933, (B) E. coli MG1655 ∆(dmsA-





Figure A.2.11. E. coli alternative terminal reductase mutants co-


















Figure A.2.12. TMAO reductase mutants are able to compete in competitive 
colonization assays. (A) E. coli EDL933 ∆(torC-torA) was able to co-colonize 
during competition with wild-type E. coli EDL933, (B) E. coli MG1655 ∆(torC-




Figure A.2.12. E. coli alternative terminal reductase mutants 

















Figure A.2.13. Nitrite reductase mutants are able to compete in competitive 
colonization assays. (A) E. coli EDL933 ∆(nirB-nirD) was able to co-colonize 
during competition with wild-type E. coli EDL933, (B) E. coli MG1655 ∆(nirB-





















Figure A.3.1. Aerobic respiratory global regulatory and cytochrome bd oxidase 
mutants exhibit colonization defects in competitive colonization assays. (A) E. 
coli MG1655 ∆arcA mutants are unable to compete during colonization with 
MG1655 ∆(cydA-cydB) mutant strains. (B) E. coli MG1655 ∆(cydA-cydB)::cat 
mutants are unable to compete during colonization with MG1655 ∆(narG)::kan  
mutant strains. (C) E. coli MG1655 ∆(cydD-cydC)::cat mutants are unable to 





Figure A.3.1. ArcA and cytochrome bd oxidase 
mutants of E. coli MG1655 exhibit colonization 















Figure A.3.2.  Primary nitrate reductase mutants exhibit colonization defects 
during competitive colonization assays with the secondary and periplasmic nitrate 
reductase. (A) E. coli MG1655 ∆(narG)::kan mutants are unable to compete 
during colonization with MG1655 ∆(narZ)::cat mutant strains. (B) E. coli 
MG1655 ∆(narG)::kan mutants are unable to compete during colonization with 





Figure A.3.2. Primary nitrate reductase mutants outcompete 


















Figure A.3.3. Nitrate reductase mutant is outcompeted by fumarate reductase in 
maintenance not initiation during competitive colonization.  E. coli MG1655 
∆narG ∆narZ::cat mutants are unable to compete initially during colonization 
with MG1655 ∆(frdA)::kan mutant strains, but able to maintain colonization in the 
mouse intestine. 
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Figure A.3.3. Fumarate reductase mutant outcompetes a nitrate reductase 
mutant of E. coli MG1655 in initiation but not maintenance. 
 218 
Table 4.1.  Strains and plasmids used in this study.  
 
    Strain or plasmid                          Relevant Characteristic(s)            Source or 
reference 
MG1655                                         Wild-type (CGSC no. 7740)   E. coli Genetic Stock  
                                                                                                           Culture Collection,  




                                   Spontaneous streptomycin-               176 






                            Spontaneous nalidixic acid-              176 
                                                          resistant mutant of MG1655  






 ∆(ubiC-ubiA)::cat     ubiCA deletion mutant of              This study 
                                                          MG1655 Str
r
, carrying cm- 




 ∆ubiE::cat                 ubiE deletion mutant of                 This study 
                                                          MG1655 Str
r
, carrying cm- 
                                                          resistance cassette 
   
MG1655 Str
r
 ∆menA::cam               menA deletion mutant of               This study 
                                                          MG1655 Str
r
, carrying cm- 
                                                          resistance cassette 
   
MG1655 Str
r
 ∆(menA-menG)::cat   menAG deletion mutant of             This study 
                                                          MG1655 Str
r
, carrying cm- 
                                                          resistance cassette 
   
MG1655 Str
r
 ∆menG::cat                menG deletion mutant of                This study 
                                                          MG1655 Str
r
, carrying cm- 
                                                          resistance cassette 
 
 




                                    Spontaneous streptomycin-                  174 






                           Spontaneous nalidixic acid-                   174 







 ∆(ubiC-ubiA)::cat      ubiCA deletion mutant of                     This study 
                                                          EDL933 Str
r
, carrying cm- 
                                                          resistance cassette 
     
EDL933 Str
r
 ∆ubiE::cam                 ubiE deletion mutant of                       This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆menA::cat                 menA deletion mutant of                      This study 
                                                          MG1655 Str
r
, carrying cm- 




 ∆(menA-menG)::cat    menAG deletion mutant of                  This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆menG::cat                 menG deletion mutant of                    This study 
                                                          EDL933 Str
r
, carrying cm- 
                                                          resistance cassette 
 
pKD3                                             Template plasmid, contains              61                                                            
                                                          chloramphenicol resistance  
          cassette flanked by FLP  
          recombinase target sites; bla cat 
   
  pKD46                                          Temperature-sensitive plasmid,            61 
                                                          contains arabinose-inducible λ phage  
                                                          red recombinase gene for linear 

















Figure A.4.1.  Ubiquinone mutants co-colonize during competitive colonization 
assays.  E. coli MG1655 ∆(ubiC-ubiA) mutants are able to compete and display no 
colonization defects during competition with wild-type E. coli MG1655. 
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Figure A.4.2.  Ubiquinone and menaquinone mutants exhibit colonization defects 
in competitive colonization assays.  (A) E. coli MG1655 ∆ubiE mutants are 
unable to compete with wild-type E. coli MG1655. (B) E. coli MG1655 ∆ubiE 




Figure A.4.2.  Mutant defective in ubiquinone and menaquinone 
















Figure A.4.3.  Demethylmenaquinone mutants exhibit colonization defects in 
competitive colonization assays.  (A) E. coli MG1655 ∆menA mutants are unable 
to compete with wild-type E. coli MG1655. (B) E. coli MG1655 ∆menA mutants 




Figure A.4.3.  Mutant defective in demethylmenaquinone synthesis 


















Figure A.4.4. (A)  E. coli MG1655 ∆(menA-menG)::cat mutant is unable to 
compete during colonization with MG1655 and wild-type strains. (B) E. coli 
MG1655 and ∆menG::cat mutants are able to compete during colonization with 




Figure A.4.4.  Mutant defective in demethylmenaquinone synthesis 
not ribosome synthesis of E. coli MG1655 exhibits colonization 
defect. 
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Table A.5.1.  Strains and plasmids used in this study.  
 
  Strain or plasmid                          Relevant Characteristic(s)            Source or 
reference 
MG1655                                         Wild-type (CGSC no. 7740)   E. coli Genetic Stock  
                                                                                                           Culture Collection,  




                                   Spontaneous streptomycin-                176 






                            Spontaneous nalidixic acid-               176 
                                                          resistant mutant of MG1655  






 ∆(malE-malG)::cat   malEFG deletion mutant of              This study 
                                                          MG1655 Str
r
, carrying cm- 




 ∆malX::cat                malX deletion mutant of                    This study 
                                                          MG1655 Str
r
, carrying cm- 




                                    menEFG malX deletion mutant         This study 
      ∆(menE-menG) malX::cat         of MG1655 Str
r
, carrying cm- 




 ∆(malP-malQ)::cat    malPQ deletion mutant of                  This study 
                                                          MG1655 Str
r
, carrying cm- 




 ∆lamB::cam                lamB deletion mutant of                    This study 
                                                          MG1655 Str
r
, carrying km- 
                                                          resistance cassette 
   
MG1655 Str
r
 ∆glgP::cam                glgP deletion mutant of                      This study 
                                                          MG1655 Str
r
, carrying cm- 
                                                          resistance cassette 
   
MG1655 Str
r
 ∆glgA::cat                 glgA deletion mutant of                      This study 
                                                          MG1655 Str
r
, carrying cm- 





 ∆glgS::cat                 glgS deletion mutant of                      This study 
                                                          MG1655 Str
r
, carrying cm- 
                                                          resistance cassette 
   
MG1655 Str
r
 ∆glgP malP::cat        glgP malP deletion mutant of            This study 
                                                          MG1655 Str
r
, carrying cm- 
                                                          resistance cassette 
 




                                    Spontaneous streptomycin-                  174      






                           Spontaneous nalidixic acid-                   174 






 ∆(malE-malG)::cat   malEFG deletion mutant of                  This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆malX::cat                malX deletion mutant of                       This study 
                                                          EDL933 Str
r
, carrying cm- 




                                    menEFG malX deletion mutant          This study 
      ∆(menE-menG) malX::cat         of EDL933 Str
r
, carrying cm- 




 ∆(malP-malQ)::cat    malPQ deletion mutant of                  This study 
                                                          EDL933 Str
r
, carrying cm- 
                                                          resistance cassette 
   
EDL933 Str
r
 ∆malP::cat                 malP deletion mutant of                    This study 
                                                          EDL933 Str
r
, carrying cm- 
                                                          resistance cassette 
   
EDL933 Str
r
 ∆malQ::cam                 malQ deletion mutant of                  This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆lamB::cat                 lamB deletion mutant of                    This study 
                                                          MG1655 Str
r
, carrying cm- 





 ∆glgP::cam                glgP deletion mutant of                     This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆glgA::cat                 glgA deletion mutant of                      This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆glgS::cat                 glgS deletion mutant of                       This study 
                                                          EDL933 Str
r
, carrying cm- 




 ∆glgP malP::cat        glgP malP deletion mutant of             This study 
                                                          EDL933 Str
r
, carrying cm- 
                                                          resistance cassette 
 
pKD3                                             Template plasmid, contains              61                                                            
                                                          chloramphenicol resistance  
          cassette flanked by FLP  
          recombinase target sites; bla cat 
  
 pKD4                                             Template plasmid, contains                61 
                                                          kanamycin resistance cassette flanked 
                                                          by FLP recombinase target sites; 
                                                          bla kan 
   
  pKD46                                          Temperature-sensitive plasmid,              
                                                          contains arabinose-inducible λ phage  
                                                          red recombinase gene for linear 
















Figure A.5.1.  Mutants in the ATP-dependent ABC transporter of the maltose 
system display colonization defects. (A) E. coli MG1655 ∆(malE-malG) mutants 
are unable to compete during colonization with MG1655 wild-type strains. 
However, the PTS system of maltose transport exhibits no phenotype in the 
intestine. (B) E. coli MG1655 ∆malX mutants are able to co-colonize in 
competition with MG1655 wild-type strains. (C) E. coli EDL933 ∆malX mutants 
are able to co-colonize in competition with EDL933 wild-type strains (D) E. coli 
MG1655 ∆malX ∆(malE-malG) mutants are unable to compete during 







Figure A.5.1.  Mutants in PTS maltose transport system in E. coli EDL933 and MG1655 
co-colonize, while ATP dependent maltose transport mutants display colonization defects 


















Figure A.5.2.  Utilization of maltose is essential for competitive colonization in 
the mouse intestine. (A) E. coli M G1655 ∆(malP-malQ) mutants are unable to 
compete during colonization with MG1655 wild-type strains. 
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Figure A.5.2.  Maltose utilization mutant in E. coli MG1655 exhibits 
















Figure A.5.3.  Mutants in the lambda receptor or maltoporin for maltodextrin 
transport exhibit no colonization defects and colonize the mouse intestine during 
competition. (A) E. coli EDL933 ∆lamB mutants are able to co-colonize with E. 
coli EDL933 wild-type strains. (B) E. coli MG1655 ∆lamB mutants are able to co-
colonize in competition with E. coli MG1655 wild-type strains. 
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Figure A.5.3.  Mutants in maltodextrin transport system in 



















Figure A.5.4.  Glycogen synthesis mutants are unable to effectively compete in 
the mouse intestine. (A) E. coli MG1655 ∆glgA mutants exhibit colonization 
defects in maintenance during competitive colonization with E. coli MG1655 
wild-type strains. (B) E. coli MG1655 ∆glgS mutants also exhibit colonization 





















Figure A.5.5.  Glycogen degradation mutants are unable to compete in the mouse 
intestine. E. coli MG1655 ∆glgP mutants exhibit colonization defects during 
competitive colonization with E. coli MG1655 wild-type. 
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Figure A.5.6.  Gluconate rescues the colonization defect observed for glycogen 
degradation mutants during competition in the mouse intestine. E. coli MG1655 





Figure A.5.6.  Mutant in glycogen degradation of E. coli MG1655 colonizes with 
wild-type E. coli MG1655 when excess gluconate is supplied. 
 
